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Abstract
Mutations in the Aristaless-related homeobox (ARX) gene are found in a spectrum of epilepsy and X-linked
intellectual disability disorders in children. During development Arx is expressed in pallial ventricular zone
(VZ) progenitor cells which give rise to the excitatory projection neurons of the cortex. Arx-/Y mice were
shown to have decreased proliferation in the cortical VZ resulting in smaller brains; however, the basis for this
reduced proliferation was not established. To determine the role of ARX on cell cycle dynamics in cortical
progenitor cells, we generated cerebral cortex specific Arx mouse mutants (cKO). The loss of pallial Arx
resulted in the reduction of cortical progenitor cells, particularly affected was the proliferation of intermediate
progenitor cells (IPCs). The mechanism was determined to be due to an overexpression of CDKN1C, an
inhibitor of cell cycle progression, in the cortical VZ and SVZ of Arx KOs throughout corticogenesis. We also
identified CDKN1C through transcriptional profile analysis of Arx KO cortices and showed that ARX is a
direct regulator of Cdkn1c transcription. Later in development and postnatally cKO corticies showed a
reduction of upper layer but not deeper layer neurons consistent with the IPC defect. The phenotype of the
adult cKO mice is different from all other Arx mutant mice. They have no discernable seizure activity and are
less anxious, less social, and more active when compared to their wild type littermates. Anatomically, there are
significant changes with reduced cortical thickness and a hypoplastic corpus callosum and anterior
commissure both consistent with a perturbation in cortical connectivity. Together, these data suggest specific
structural and behavioral anomalies, common in patients with ARX mutations, are specifically due to
alterations in pallial progenitor function. Furthermore, and of considerable interest, our data demonstrate that
some of the neurobehavioral features found in patients with ARX mutations are not due to on-going seizures,
as is often postulated, as the confounding variable of epilepsy was eliminated in these behavior analyses.
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ABSTRACT 
 
ARX INFLUENCES CORTICAL FUNCTION BY REGULATING PROGENITOR CELL 
PROLIFERATION 
Jacqueline Simonet 
Jeffrey Golden 
Eric Marsh 
Mutations in the Aristaless-related homeobox (ARX) gene are found in a spectrum of epilepsy and 
X-linked intellectual disability disorders in children.  During development Arx is expressed in 
pallial ventricular zone (VZ) progenitor cells which give rise to the excitatory projection neurons 
of the cortex.  Arx-/Y mice were shown to have decreased proliferation in the cortical VZ resulting 
in smaller brains; however, the basis for this reduced proliferation was not established.  To 
determine the role of ARX on cell cycle dynamics in cortical progenitor cells, we generated 
cerebral cortex specific Arx mouse mutants (cKO).  The loss of pallial Arx resulted in the 
reduction of cortical progenitor cells, particularly affected was the proliferation of intermediate 
progenitor cells (IPCs).  The mechanism was determined to be due to an overexpression of 
CDKN1C, an inhibitor of cell cycle progression, in the cortical VZ and SVZ of Arx KOs 
throughout corticogenesis.  We also identified CDKN1C through transcriptional profile analysis 
of Arx KO cortices and showed that ARX is a direct regulator of Cdkn1c transcription.  Later in 
development and postnatally cKO corticies showed a reduction of upper layer but not deeper 
layer neurons consistent with the IPC defect.  The phenotype of the adult cKO mice is different 
from all other Arx mutant mice.  They have no discernable seizure activity and are less anxious, 
less social, and more active when compared to their wild type littermates.  Anatomically, there 
are significant changes with reduced cortical thickness and a hypoplastic corpus callosum and 
anterior commissure both consistent with a perturbation in cortical connectivity.  Together, these 
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data suggest specific structural and behavioral anomalies, common in patients with ARX 
mutations, are specifically due to alterations in pallial progenitor function.  Furthermore, and of 
considerable interest, our data demonstrate that some of the neurobehavioral features found in 
patients with ARX mutations are not due to on-going seizures, as is often postulated, as the 
confounding variable of epilepsy was eliminated in these behavior analyses. 
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CHAPTER 1: Introduction 
 
Epilepsy, intellectual disability, and other neurological disorders are major causes 
of childhood morbidity and mortality.  The development of effective therapies relies, in 
part, on determining the pathogenic mechanisms of these various disorders.  
Complicating this process is the increasing recognition that identification of a specific 
genetic mutation does not, a priori, immediately elucidate the neurobiologic defect 
resulting in a particular disorder.  In order to understand how known mutations in 
particular genes affect brain development and function we first need to understand how 
those genes function in normal brain development.  My thesis work has focused on 
beginning to answer these questions for one particular gene, Arx, in the cerebral cortex of 
mice.  
Development of the Cerebral Cortex 
 Understanding how changes in one gene affect cerebral cortical development 
requires first appreciating normal cortical development.  Early in development the 
embryo consists of three cell layers, the inner most layer is the endoderm, the middle is 
the mesoderm, and the outer most layer is the ectoderm.  The ectoderm gives rise to the 
central and peripheral nervous system along with the integumentary system.  Shortly after 
the development of these three embryonic layers a central sheet of cells are specified as a 
neural plate at the dorsal midline of the embryo.  The neural plate morphs into a neural 
tube due to proliferation, invagination, and pinching off of ectodermal cells from the 
surface (Alvarez IS and GC Schoenwolf 1992; Lawson A et al. 2001; Gilbert SF 2010).  
After the most anterior part of the neural tube has closed it begins to form bulges or 
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vesicles.  The most anterior bulge, the prosencephalon, eventually becomes the forebrain 
of the embryo.  As brain development proceeds this single vesicle divides in the anterior-
posterior plane to become two vesicles, the telencephalon and the diencephalon.  Over 
time the most anterior vesicle, the telencephalon, expands significantly in the medial 
lateral plan to become the large, bilaterally symmetric cerebral hemispheres.  The cells in 
these vesicles will ultimately give rise to the cerebral cortex, hippocampus, basal ganglia, 
and olfactory bulbs. (For review see (Kandel ER et al. 2000; Gilbert SF 2010))  
During these early developmental stages the telencephalon is made up of 
primarily progenitor cells, which continually proliferate to generate more progenitor cells 
(Gotz M and YA Barde 2005).  The progenitor cells in the dorsal aspect of the 
telencephalic vesicle, also called the pallium, give rise to the cerebral cortex.  These 
dorsal progenitor cells, termed radial glial progenitor cells (RGCs), are located adjacent 
to the ventricle in the ventricular zone (VZ) (Malatesta P et al. 2000; Dehay C and H 
Kennedy 2007) (Chapter 1; Figure 1).  These RGCs produce three different types of cells: 
More radial glia progenitor cells, differentiated neurons, and intermediate progenitor cells 
(IPCs) that will form a second layer of cells further away from the ventricle called the 
subventricular zone (SVZ) (Noctor SC et al. 2004; Gal JS et al. 2006; Dehay C and H 
Kennedy 2007) (Chapter 1; Figure 1).  These IPCs will divide once to several times 
giving rise to more IPCs and ultimately neurons (Noctor SC et al. 2004; Dehay C and H 
Kennedy 2007).  Together the RGCs and the IPCs will give rise to all of the projection 
(glutamatergic excitatory) neurons, in the cerebral cortex.   
  3 
Another striking feature of cerebral cortical development is that the normal six-
layered neocortex develops in a highly ordered manner.  The first neurons to exit the cell 
cycle and begin differentiation will migrate up away from the ventricle and begin to form 
the cortex structure by residing in what will ultimately be the deepest layer of the cortex, 
layer 6 (Frantz GD and SK McConnell 1996; Kandel ER et al. 2000).  Subsequent 
neurons migrate past layer 6 neurons and begin populating what will eventually be layer 
5.  This inside out process of development continues until neurons populate all six layers 
(Frantz GD and SK McConnell 1996; Kandel ER et al. 2000).  Glial cells that will 
support the maturation and function of these neurons are subsequently produced from the 
RGCs and will migrate up into all of the layers of the cortex (Bayer SA and J Altman 
1991; Miller FD and AS Gauthier 2007).  The outer most layer, known as the molecular 
layer or layer 1, is formed early in development from a unique population of neurons 
known as Cajal-Rietzius cells.  This layer is formed prior to the deeper layers when the 
RGCs are still clonally proliferating.  The Cajal-Rietzius cells help to direct the migration 
of the other neurons and glia into their appropriate layers (Meyer G et al. 2002; Hevner 
RF et al. 2003; Takiguchi-Hayashi K et al. 2004; Bielle F et al. 2005; Soriano E and JA 
Del Rio 2005). 
There is currently some controversy regarding which cortical layers the IPCs 
contribute neurons to.  As was previously described IPCs are produced by the RGCs 
early in development and they, in turn, replicate themselves and ultimately differentiate 
into neurons but not glia.  Some evidence exists to support IPCs producing excitatory 
neurons that will reside in all layers of the cortex.  Other evidence suggests that IPCs 
only produce superficial or upper layer neurons (for review see (Kriegstein A et al. 2006; 
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Pontious A et al. 2008)).  The upper layer neuron hypothesis is supported mainly by the 
fact that upper layer molecular markers (Cux1, Satb2, Cux2, Svet1) are expressed in IPCs 
both before and during neurogenesis of upper layer neurons (Tarabykin V et al. 2001; 
Nieto M et al. 2004; Zimmer C et al. 2004; Britanova O et al. 2005).  The IPCs reside in 
and form the SVZ during the time when the upper layer neurons are being generated.  
Thus the timing is right for the IPCs to give rise to upper layer neurons and not lower 
layer neurons (Takahashi T et al. 1999; Gotz M and L Sommer 2005).  However, there is 
also evidence that IPCs during development produce neurons from all neocortical layers 
even before the SVZ is formed (Kowalczyk T et al. 2009).  There is currently no direct 
evidence that IPCs produce only upper layer neurons versus neurons in all layers, thus 
this point remains to be experimentally determined.  
 There are more than excitatory neurons in the neocortex. Inhibitory neurons, or 
interneurons, comprise twenty percent of the adult neuronal population of the cerebral 
cortex, and are derived from a completely separate progenitor source (Faux C et al. 2010; 
Le Magueresse C and H Monyer 2013).  These cortical interneurons develop ventrally in 
the subpallial compartment of the telencephalon in three regions known as the caudal, 
medial, and lateral ganglionic eminences (Chapter 1; Figure 1).  They are embryonic 
structures located in what ultimately is the region of the basal ganglia in the adult 
(Wonders C and SA Anderson 2005; Marin O 2013).  Analogous to the dorsal 
telencephalon, the medial ganglionic eminence progenitor cells will first divide to self 
replicate and later in development, beginning around embryonic day 10.5, they will begin 
to produce differentiated premature interneurons (Ross ME 2011; Le Magueresse C and 
H Monyer 2013).  These developing interneurons will migrate dorsally up into the cortex 
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at the same time that the excitatory neurons are being produced by the RGCs and 
migrating radially to form the layers of the cortex (Faux C et al. 2012; Kwan KY et al. 
2012; Marin O 2013) (Chapter 1; Figure 1).  The interneurons integrate into the forming 
cortex in the same inside out manner as the excitatory neurons with the first interneurons 
populating the deeper layers and the last ones populating the most superficial layers 
(Miyoshi G and G Fishell 2011; Faux C et al. 2012; Kwan KY et al. 2012).   
Once both the excitatory neurons and the interneurons have reached their final 
destinations they begin to send out axons to make connections with other neurons 
(Kandel ER et al. 2000; Lagercrantz H and T Ringstedt 2001).  The excitatory neurons 
will make connections with adjacent neurons, neurons in other layers of the cortex, 
neurons in other neocortical regions, or send projections to other subcortical regions 
(Kandel ER et al. 2000; Innocenti GM and DJ Price 2005; Price DJ et al. 2006).  The 
interneurons will primarily make local connections with neighboring cortical neurons 
since they are responsible for the coordination and regulation of cortical-cortical circuits 
(Kandel ER et al. 2000; Woo NH and B Lu 2006).  After the axons have found their 
correct targets they will form synapses on the dendrites of other neurons to form complex 
circuits.  Synapses are strengthened by activity and lost if inactive, a process called 
pruning (Kandel ER et al. 2000; Lagercrantz H and T Ringstedt 2001; Innocenti GM and 
DJ Price 2005).  Through these processes the early brain is wired.  
The cerebral cortex is organized into columnar functional units and groups of 
these units are then further organized into functional modules that control different tasks 
such as motor control or vision (Sansom SN and FJ Livesey 2009). Within any column of 
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cortex from the pial surface, the outer surface of the brain, to the ventricle the cells all 
have connections to each other and will all be activated together (Kandel ER et al. 2000; 
Sansom SN and FJ Livesey 2009).  It is hypothesized that all of the cells born from a 
single RGC may form a column together (Kornack DR and P Rakic 1995; Sansom SN 
and FJ Livesey 2009).  Within each column the cells in each layer make particular types 
of connections.  In general the excitatory neurons in layers 2 and 3 project locally and to 
the opposite side of the cortex across the white matter tract called the corpus callosum 
with their axons terminating in layer 4 of the contralateral cortex (Kandel ER et al. 2000; 
Thomson AM and C Lamy 2007; Sansom SN and FJ Livesey 2009).  Layer 4, which is 
the primary input layer to the cortex, also receives inputs from the thalamus.  Neurons in 
the deeper layers, 5 and 6, primarily project to layer 1 or layer 6, but these are feedback 
projections rather than feed-forward (Kandel ER et al. 2000; Thomson AM and C Lamy 
2007; Sansom SN and FJ Livesey 2009).  Neurons in layer 5 predominately project out of 
the cortex to subcortical regions including down the spinal cord (Kandel ER et al. 2000; 
Thomson AM and C Lamy 2007; Sansom SN and FJ Livesey 2009).  
Neuronal development disorders 
 Mutations in a variety of genes can disrupt any or all of these developmental 
processes and result in a spectrum of conditions.  Some mutations lead to structural brain 
malformations while other mutations alter the circuitry, synapses, or function and lead to 
intellectual disability, and epilepsy.  Genetic studies in a host of different brain 
malformations has led to the discovery of genes involved in regulating proliferation, 
migration, and cortical organization, among a host of other processes.  Mutations have 
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been identified in genes involved in transcriptional regulation, cell cycle regulation, 
centrosome maturation and duplication, spindle formation, and DNA repair cause 
changes in proliferation and apoptosis of cortical progenitor cells (Barkovich AJ et al. 
2012).   These mutations lead to malformations such as microcephaly (small brain with 
fewer neurons) megalencephalies (large brain with more neurons), and focal or diffuse 
dysgenesis (areas of increased or decreased cortex size) (Manzini MC and CA Walsh 
2011; Barkovich AJ et al. 2012).   
Mutations in genes involved in structural and regulatory components of the 
cytoskeletal and the centrosome can cause problems with initiation, progression, and 
direction of migration.  This leads to malformations such as periventicular heterotopia 
(problems with initiation of migration resulting in disorganized groups of neurons at the 
ventricle), subcortical heterotopia (problems with the direction of migration resulting in 
disorganized groups of neurons in the white matter), lissencephaly (problems with 
continuation and direction of migrations which results in a loss of the normal gyrated 
surface, a thickened neocortex, and a smooth brain), polymicrogyria (multiple small 
gyri), and cobblestone malformations (an overmigration of neurons resulting in 
disorganized groups of neurons at the pial surface of the brain) (Manzini MC and CA 
Walsh 2011; Barkovich AJ et al. 2012). 
Mutations in genes involved in neuronal specification, projection, and the 
formation of synapses can cause changes in cortical organization and function. This leads 
to malformations such as focal dysplasia (areas of layer disorganization) and some 
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instances of polymicrogyria (multiple small gyri) (Manzini MC and CA Walsh 2011; 
Barkovich AJ et al. 2012).  
The role of Arx in cortical development 
Several genes do not fit neatly into any of these categories. One example is the 
Aristaless-related homebox gene (ARX/Arx), which is a transcription factor that is 
expressed in the developing hypothalamus, thalamus, basal ganglia, and cerebral cortex.  
It appears to regulate proliferation, specification, migration, and differentiation of various 
populations of neurons in these areas of the brain (Marsh ED and JA Golden 2012).  Arx 
is on the X-chromosome thus most ARX patients are male as one normal allele is 
sufficient for normal brain development.  There are currently 44 different mutations of 
ARX that have been found in humans (Shoubridge C et al. 2010) (Chapter 1; Figure 2).  
These mutations cause a spectrum of phenotypes from lissencephaly and 
hydranencephaly to mutations that cause no brain malformations, but do lead to 
intellectual disability and epilepsy.   
One explanation for the different phenotypes associated with different mutations 
of the same gene is that mutations in different parts of the gene affect the function of the 
gene in different ways.  In the case of ARX, more severe patient phenotypes, those that 
have brain malformations such as lissencephaly, are the result of either complete loss of 
function of the gene (deletions or truncations) or from mutations in the homeodomain 
region of the gene, which prevents Arx from to binding to DNA (Chapter 1; Figure 2).  
Point mutations and missense mutations that do not occur in the homeodomain tend to 
result in milder phenotypes that rarely include structural brain anomalies, but do include 
  9 
moderate intellectual disability and epilepsy (Chapter 1; Figure 2).  The exception to this 
rule is the polyalanine expansion mutations in the second polyalanine tract. These are the 
most common type occurring in about 40% of patients with an ARX mutation 
(Shoubridge C et al. 2010). These mutations can result in patients with a spectrum of 
phenotypes such as mild intellectual disability, moderate intellectual disability and 
dystonic hand movements (Parrington syndrome), moderate intellectual disability and 
infantile spasms, a particular type of epilepsy (West syndrome), or severe intellectual 
disability and early onset tonic spasms (Ohtahara syndrome) (Shoubridge C et al. 2010) 
(Chapter 1; Figure 2).   
In order to look at the role of Arx in brain development and how mutations in this 
gene can lead to this pleiotropy of phenotypes in humans a mouse with no Arx expression 
(Arx-/Y) was created in 2002.  This Arx-/Y mouse dies shortly after birth most likely due to 
seizures or an inability to feed (Kitamura K et al. 2002).  These mice have a thinner 
cortex and decrease proliferation in the cortex during development, but migration of the 
post mitotic excitatory neurons into the cortex seemed to be relatively normal (Kitamura 
K et al. 2002).  The Arx-/Y mice also have abnormal nerve fiber tracts such as the corpus 
callosum, thalamo-cortical tract, fimbria, and hippocampal commissure (Kitamura K et 
al. 2002).  In addition, the Arx-/Y mice have deficiencies in interneuron migration into the 
cortex and this led to mislocalization of interneurons in the cortex in addition to a loss of 
particular subtypes of interneurons (Kitamura K et al. 2002).   
Mutant mice have also been generated with a series of ARX mutations seen in 
human patients (Kitamura K et al. 2009; Price MG et al. 2009).  Two of the mutations are 
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point mutations in the homeodomain (P353L and P353R) and two others are expansions 
in the first polyalanine tract (330ins(GCG)7) and (10+7(GCG)) (Kitamura K et al. 2009; 
Price MG et al. 2009).  In humans these mutations all produce very different phenotypes; 
the P353L mutation results in myoclonic epilepsy and intellectual disability, the P353R 
mutation results in XLAG (x-linked lissencephaly with ambiguous genetalia), and the 
polyalanine expansion results in West syndrome (infantile spasms and intellectual 
disability) (Kitamura K et al. 2009).  Mice harboring the P353R (ArxPR/Y) mutation die 
shortly after birth and have small brains similar to Arx-/Y mice (Kitamura K et al. 2009).  
Also similar to Arx-/Y mice, they have thinner cortices a loss of upper layer neurons, and 
an expansion of deeper layer neurons (Kitamura K et al. 2009).  The ArxPR/Y mice also 
showed very little migration of interneurons into the cortex.  Therefore, this mouse seems 
to be a good model of its human mutation and since it is similar to the Arx-/Y mouse, the 
Arx-/Y mouse can also be used as a model for human patients with these types of 
mutations. 
The P353L knock-in mice (ArxPL/Y) and the polyalanine expansion mice 
(Arx(GCG)7/Y) have normal sized brains and cortices and with no change in cell layers 
(Kitamura K et al. 2009).  Both the ArxPL/Y mice and the Arx(GCG)7/Y mice have delayed 
migration of their interneurons into the cortex and the ArxPL/Y  mice have a slight 
reduction of interneurons in the cortex and the Arx(GCG)7/Y mice have a more severe 
reduction of interneuron numbers (Kitamura K et al. 2009).  Most of the Arx(GCG)7/Y mice 
have seizures and die by around three months of age while the ArxPL/Y mice have a 
normal lifespan and did not have seizures, but did have a lower threshold when 
challenged with seizure inducing drugs (Kitamura K et al. 2009).  In addition to their 
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more severe seizure phenotype the Arx(GCG)7/Y mice also have a more severe behavioral 
phenotype than the ArxPL/Y mice.  The Arx(GCG)7/Y mice showed impaired aversive, spatial, 
and procedural learning whereas the ArxPL/Y mice only showed impaired aversive and 
spatial learning.  In addition the Arx(GCG)7/Y mice were also anxious and hyperactive and 
the ArxPL/Y mice were not (Kitamura K et al. 2009).  While recognizing these mice are not 
perfect models of the human phenotypes they do seem to mirror the severity of the 
human phenotypes.  This indicates that the impairments to the function of Arx in each 
mutation is probably similar between mice and humans and therefore these mice are a 
reasonable model to further study the function of ARX and ARX mutations in patients. 
 A second polyalanine tract expansion mouse was made by again inserting 7 
(GCG) codons inserted similar to the other polyalanine tract expansion mouse, but in a 
different location in the polyalanine tract (Arx(GCG)10+7) (Price MG et al. 2009).  These 
mice exhibit a similar behavioral and morphological phenotype to the Arx(GCG)7/Y mice.  
One exception to this is that the Arx(GCG)10+7 mice were found to be less anxious and not 
hyperactive which is the opposite of the Arx(GCG)7/Y mice (Price MG et al. 2009).  These 
mice (Arx(GCG)7/Y) were shown to have seizures with similarities to the infantile spasms 
observed in human patients as early as nine days of age (Price MG et al. 2009).  The 
Arx(GCG)7/Y mice also displayed social deficits in the social dominance tube test (Price MG 
et al. 2009).  This second polyalanine tract expansion mouse (Arx(GCG)7/Y) confirms that 
mouse models of human ARX mutations can be made and can serve as models for the 
human disease. 
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Arx mutant mice and human ARX patients have defects in many parts of their 
brains, but also in other parts of their bodies which led scientists to investigate where Arx 
is expressed during development and in the adult.  Arx is first expressed in the anterior 
neural plate before neural tube closure.  After neural tube closure it is expressed in the 
neural stem cells lining the bulges that will become the telencephalon (Colombo E et al. 
2004).  As development proceeds its expression can be found in the ventral thalamus, the 
floorplate of the developing spinal cord, the myotome which will give rise to the body 
muscles, the pancreas, the stomach, and the testes (Colombo E et al. 2004).  In adults Arx 
expression is restricted to interneurons in the cerebral cortex and the olfactory bulb and 
adult neural stem cells (Colombo E et al. 2004).  
In the developing cerebral cortex Arx shows distinct expression patterns in 
different neuronal populations.  Arx is expressed in the medial ganglionic eminence, an 
embryologic structure in the ventral telencephalon is the origin of cortical interneurons 
(Kitamura K et al. 2002).  Cortical interneurons are physiologically inhibitory and play 
central roles in modulating activity in cortical-cortical circuits.  Arx expression begins in 
these neurons as they become post mitotic and begin migrating and continues to be 
expressed in the mature interneurons (Kitamura K et al. 2002; Colombo E et al. 2004).   
Arx is also expressed in the dorsal telencephalic region that gives rise to 
projection (excitatory) neurons.  Expression is observed in the cortical progenitor cells 
and intermediate progenitor cells (VZ and SVZ respectively) as the cells are proliferating 
to generate the excitatory neurons and the glia cells that will populate the cerebral cortex 
  13 
(Colombo E et al. 2004).  However, in contrast to the interneuron population, Arx is 
downregulated as these cells become post mitotic and begin to migrate.   
Thus far much of the work on Arx in the brain has focused on its role in 
interneuron development with less focus on its role in the cortical progenitor cells.  A 
conditional knockout mouse was engineered with floxed sites around exon 2, which 
contains the first part of the homeodomain (Fulp CT et al. 2008).  This mouse has been 
used to remove Arx specifically from the developing interneurons (Arx-/Y Dlx5/6Cre) 
(Marsh E et al. 2009).  Male Arx-/Y Dlx5/6Cre mice all had abnormal background EEGs 
and spontaneous seizures, which suggests that loss of Arx in the interneurons is sufficient 
to cause epilepsy and could be the pathogenesis in human patients (Marsh E et al. 2009).   
Unexpectedly, half of the female heterozygous Arx-/X Dlx5/6Cre mice had seizures 
and abnormal background EEGs, which is consistent with the theory that random X 
inactivation would cause some females to be more severely affected than others (Marsh E 
et al. 2009).  In humans most ARX patients are males, since ARX is on the X-
chromosome, and their mothers are carriers and have a normal phenotype though some of 
them have agenesis of the corpus callosum (Marsh E et al. 2009).  However, when other 
female relatives of the male patients are examined two thirds of them were found to have 
some type of neurological symptoms (Marsh E et al. 2009).  This would suggest that 
perhaps the mothers of the ARX patients might have skewed X-inactivation such that the 
majority of their cells are expressing the X with the normal ARX allele and the other 
female relatives either have normal X-inactivation or X-inactivation skewed towards 
expression of the mutant ARX allele.  However, when the X-inactivation studies were 
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conducted in these female relatives skewed inactivation was not observed (Marsh E et al. 
2009).  
Other research on the role of Arx in interneurons has focused on both how it is 
regulated and what genes it regulates.  In interneurons Arx expression is regulated by the 
transcription factors Dlx1 and 2 (Cobos I et al. 2005; Colasante G et al. 2008).  Arx then 
regulates many genes involved in migration during early development, such as Cxcr7 and 
Cxcr4 (chemokine receptors used to direct migration) and specification, such as Magel2 
(Fulp CT et al. 2008; Colasante G et al. 2009; Friocourt G and JG Parnavelas 2011).  
Later during interneuron development Arx regulates genes involved in axonal projection, 
such as Slt2 and Sema6a (ligands involves in axon guidance) (Fulp CT et al. 2008; 
Colasante G et al. 2009; Friocourt G and JG Parnavelas 2011).  Two microarrays have 
been done on Arx deficient developing interneurons, but so far only 3 genes (Lmo1, Ebf3, 
and Shox2) have been shown to be direct targets of Arx in interneurons (Fulp CT et al. 
2008).  Only one of these genes (Ebf3) has been shown to be necessary for the migration 
of interneurons (Colasante G et al. 2009).   
Both of these microarrays provide in vivo support for the theory that Arx 
primarily acts as a transcriptional repressor since the majority of genes found were 
upregulated in the Arx deficient interneurons (Fulp CT et al. 2008; Colasante G et al. 
2009).  The array experiments confirmed earlier in vitro data demonstrating that Arx acts 
as a transcriptional repressor and binds to Groucho/transducin-like enhancer of split 
(TLE) proteins (McKenzie O et al. 2007).  Several recent studies have begun to explore 
how different mutations of Arx can change its ability to regulate the transcription of 
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particular genes.  Arx protein, which has a polyalanine tract expansion mutation similar 
to those seen in ARX patients, is still capable of binding to DNA but fails to repress some 
of the genes that it can normally repress (Nasrallah MP et al. 2012).  Arx with the 
polyalanine tract expansion fails to repress Ebf3 or Shox2, but still represses Lmo1 in 
cells and knock in mice with this mutation (Nasrallah MP et al. 2012).  This appears to be 
due to the fact that Arx with the polyalanine tract expansion mutation can no longer bind 
to its cofactor Tle1 and therefore can no longer repress a subset of its target genes 
(Nasrallah MP et al. 2012).  Another study found that most point mutations in the 
homeodomain of Arx, which result in the most severe human phenotypes, fail to repress 
Lmo1 and Shox2 and fail to bind to DNA (Cho G et al. 2012; Shoubridge C et al. 2012).  
In addition point mutations in the nuclear localization signal of Arx also appear 
mislocalized to the cytoplasm (Shoubridge C et al. 2012).  There is also some evidence 
that the binding of different proteins to Arx could change its affinity for particular DNA 
binding sites (Cho G et al. 2012).  Together, these data begin to provide some insight into 
why different mutations of ARX can result in such different phenotypes.  
 Even though the Arx-/Y mice had defects in the development of both the excitatory 
projection neurons and the inhibitory interneurons in the cortex.  Most of the research in 
the field has focused on the role of Arx in interneurons and its role in cortical progenitor 
cells has been less extensively studied.  One exception to this is a study, which examined 
the role of Arx in the progenitor cells in the cortex using in utero electroporated plasmids 
containing either an shRNA against Arx or an overexpression of Arx into the embryonic 
mouse brain at embryonic day 13.5 (Friocourt G et al. 2008).  When Arx was inactivated 
with the shRNA construct fewer transfected cells were found in the VZ of the cortex and 
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fewer of them were mitotic.  In contrast, when Arx was overexpressed there were more 
transfected cells in the VZ of the cortex and more of them are stuck in the cell cycle with 
a longer synthesis phase of the cell cycle and a longer overall cell cycle length (Friocourt 
G et al. 2008).  In addition, when Arx was either inactivated or overexpressed using these 
constructs in utero the migration of the excitatory cells into the cortex was disrupted such 
that they did not reach the cortex as quickly and had abnormal morphology during 
migration (Friocourt G et al. 2008).   
 This paper further supported the hypothesis that Arx plays a role in regulating 
proliferation and possibly radial migration in the development of the excitatory cells of 
the cortex.  However, the design of their experiments makes several of the results 
difficult to interpret.  By only observing one time point during development and knocking 
down or overexpressing Arx after cortical development has already begun there is no way 
to know if Arx has a role earlier in development or how the partially developed cortex 
may impact the later loss of Arx.  As they did not follow any of the electroporated pups 
through to postnatal times we do not know if the radially migrating excitatory neurons are 
completely inhibited from reaching the cortex or whether they are simply delayed.  
Another problem with these experiments is the lack of specificity in the transfections or 
analysis of the transfected cells.  It is assumed only VZ cortical progenitor cells are 
transfected, without confirmation.  Since Arx expression is only altered mid way through 
development and only some progenitor cells are altered these experiments do not 
recapitulate well the dysfunction of mutant ARX in developing human brain.   
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 To better analyze the role of Arx in the progenitor cells of the cortex and examine 
how loss of Arx in these cells affects cortex development and function we took advantage 
of our floxed allele to remove Arx from the cortical VZ (Fulp CT et al. 2008).  To do this 
we mated our Arx floxed mice (ArxF/X) to Emx1Cre mice.  Emx1 is a transcription factor 
that is expressed in the dorsal part of the developing telencephalon starting at embryonic 
day 9.5 of development.  Mating these mice together produced male mice with no Arx 
expressed in their cortical progenitor cells during development, but preserved Arx in the 
interneuron precursors. We then assayed proliferation, cell cycle dynamics, and cortical 
layer formation in late stage embryogenesis and adult mice.  We also identified a possible 
cell cycle regulatory gene that could be repressed by Arx in order to control cortical 
progenitor cell proliferation and differentiation and thereby control cortical layer 
formation.  Finally, we examined the behavioral phenotype of these mice in order to 
determine what role the cortical malformations verses the loss of interneurons plays in 
the patient phenotypes.  This research has led to a better understanding of the role Arx 
plays in cortical development and it has also led to a better understanding of how 
mutations in Arx cause the behavioral deficits seen in human patients. 
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Figure 1: Cortical interneurons arise in the ventral telencephalon and migrate up into the 
cortex (blue arrow), while the excitatory neurons arise in the dorsal telencephalon and 
migrate out into the cortex (red arrows).  The excitatory neurons come from two types of 
progenitor cells the radial glia cells (red) and intermediate progenitor cells (orange).  Radial glia 
cells can divide to give rise to more of themselves, they can divide to produce differentiated 
neurons which will migrate out into the cortex, or they can divide to produce intermediate 
progenitor cells.  Intermediate progenitor cells divide to give rise to more of themselves and to 
differentiated neurons. 
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Figure 2: Schematic of the ARX protein showing the functional domains of the protein and 
the locations of different mutations seen in patients.  ARX (Aristaless related homeobox 
transcription factor) has an aristaless (Arist) domain at it C-terminal, an octapeptide (OP) domain 
at its N-terminal, a homeodomain which binds to DNA surrounded by nuclear localization signals 
(NLS), and four polyalanine tracts (PA).  The most severe mutations of ARX, which result in 
brain malformations; such as XLAG (X-linked lissencephaly with ambiguous genitalia), HYD-
AG (hydranencephaly with ambiguous genitalia), and Proud syndrome are caused by deletions 
(Del), frameshifts (fs), and point mutations in the homeodomain.  Less severe mutations of ARX, 
which result in epilepsy and intellectual disability syndromes; such as Ohtahara, IEDE (idiopathic 
infantile epileptic dyskinetic encephalopathy), West syndrome, XMESID (X-linked myoclonic 
seizures, spasticity and intellectual disability), Partington syndrome, and non-specific X linked 
intellectual disability (XID) are caused by expansions of the polyalanine tracts and by point 
mutations elsewhere in the gene. 
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CHAPTER 2: ARX regulates cortical intermediate progenitor cell expansion and 
upper layer neuron formation through repression of Cdkn1c 
 
Introduction 
Mutations in the Aristaless-related homeobox gene (ARX) are a common cause of 
X-linked intellectual disability.  Over 40 different mutations have been identified in ARX 
resulting in a spectrum of disorders that vary from mild intellectual disability with no 
brain malformations to severe brain malformations such as lissencephaly and 
hydranencephaly (Gecz J et al. 2006).  Currently the pathogenesis of these ARX related 
disorders are poorly defined. 
During mouse cerebral cortical development Arx is expressed in the ventricular 
zone (VZ) (Colombo E et al. 2004; Friocourt G et al. 2006; Colasante G et al. 2008).  Arx 
deficient mice die shortly after birth with a thin and disorganized neocortex in addition to 
other brain abnormalities (Kitamura K et al. 2002).  The neocortical alterations appear to 
be the result of decreased pallial progenitor cell proliferation (Kitamura K et al. 2002; 
Friocourt G et al. 2008).  However, it remains unclear how Arx regulates cortical 
progenitor cell proliferation, cell specification and layer formation in the neocortex.  
To define the endogenous function of Arx in the cortical VZ, Arx floxed mice 
were mated to Emx1Cre mice, removing Arx specifically in the dorsal telencephalon.  The 
number and proliferation rate of progenitor cells, their cell cycle length, and final cortical 
laminar fate were then assayed.  Our data show that Arx regulates the expansion of both 
radial glial cells (RGC) and intermediate progenitor cells (IPC), with a more pronounced 
effect on the latter.  The decrease in proliferation in the Arx cKO mice resulted in a loss 
of neurons specifically in the upper layers of the neocortex.  This is consistent with the 
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hypothesis that IPC derived neurons contribute to all cortical layers, but predominately 
upper layers (Tarabykin V et al. 2001; Nieto M et al. 2004; Zimmer C et al. 2004; Sessa 
A et al. 2008). 
We also identified a cohort of genes whose expression is consistently altered in 
Arx KO mice cortices when compared to wild type mice.  Among them, Cdkn1c, 
encoding for CDKN1C, was found to be a direct target and its role in the identified IPC 
phenotype was analyzed.  As a member of the Cip/Kip family of cyclin dependent kinase 
inhibitors (CDKi), CDKN1C antagonizes cell cycle progression by inhibiting G1/S 
transition (Sherr CJ and JM Roberts 1999).  Interestingly, CDKN1C, whose expression is 
normally detected in the cortical SVZ, was overexpressed in both the VZ and SVZ of Arx 
KO cortices.  Thus, ARX appears to regulate cortical progenitor pool expansion by 
repressing the premature expression of Cdkn1c in the cerebral cortex.    
 
Methods   
Mice 
Arx conditional knockout mice (Arxfl/fl) (Fulp et al., 2008) and Arx knockout mice 
(Arx-/y) (Collombat P et al. 2003) were maintained on a C57Bl/6 background.  Timed-
pregnant mice were considered embryonic day 0.5 (E0.5) on the morning of the 
confirmation of the vaginal plug.  To inactivate Arx in the dorsal telencephalon during 
development Arxfl/y mice were crossed with Emx1Cre animals (Jin XL et al. 2000).  
Genotyping of Arx conditional knockout and germline knockout mice was performed as 
described (Jin XL et al. 2000; Collombat P et al. 2003; Fulp CT et al. 2008). 
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Tbr2::GFP transgenic mice (Kwon GS and AK Hadjantonakis 2007) were crossed 
with Arxfl/y; Emx1Cre animals.  Mice were maintained at the Children’s Hospital of 
Philadelphia and at the San Raffaele Scientific Institute Institutional, lab animal facilities.  
All experiments were approved by the Institutional Animal Care and Use Committees of 
the Children’s Hospital of Philadelphia and of San Raffaele Scientific Institute, Milan. 
BrdU administration for cell cycle dynamic analysis 
BrdU was administered (50 mg/kg, i.p.) to pregnant mice 1 h before embryo 
harvesting to assess the S-phase labeling index.  A cumulative BrdU labeling protocol 
was followed to determine the growth fraction (GF) (fraction of the cell population that is 
proliferative), to determine the time to reach the growth fraction (Tc − Ts), and, 
subsequently, to estimate the length of the cell cycle (Tc) and the duration of S-phase 
(Ts) for both radial glia and intermediate progenitors (Takahashi T et al. 1995).  Pregnant 
mice were injected with BrdU (50 mg/kg, i.p.) starting at E13.5, with injections every 3 
hours and with survival times of 0.5 h.  Thus, a total of six time points were examined: 
0.5 h, 3.5 h, 6.5 h, 9.5 h, 12.5 h and 15.5 h.  For cell cycle exit experiment, BrdU (50 
mg/kg, i.p.) was injected in a pregnant female at E13.5 and 24 hours later embryos were 
harvested and processed for analysis. 
Histological techniques 
Nissl staining 
Sections were stained in a 0.1% cresyl violet solution for 5-10 minutes and then, 
rinsed quickly in distilled water.  Thereafter, sections were dehydrated in 100% ethanol 
(2x5 min), dried and coverslipped with Eukitt (Electron Microscopy Science). 
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RNA in situ hybridizations 
ISH on frozen sections was performed as previously described by (Schaeren-
Wiemers N and A Gerfin-Moser 1993) with the modifications previously reported 
(Colombo E et al. 2007).  Cdkn1c in situ probe was a kind gift of Dr. L. Muzio (Muzio L 
et al. 2002). 
Immunohistochemistry 
Whole heads (E11.5 and E12.5) or brains were dissected from embryonic and P1 
mice and fixed over night in 4% PFA at 4°C. P14 and P30 mice were perfused with 4% 
PFA and then the brains were removed and fixed in 4% PFA overnight at 4°C.  Fixed 
brains were frozen and 10um-thick coronal section were obtained.  Antigen retrieval was 
performed in citric acid-based Antigen Unmasking Solution (Vector Laboratories) 
autoclaved at 105 °C for 10 minutes and BrdU staining where slides were treated with 2N 
HCl for 20 minutes.  No antigen retrieval was performed for ARX and TBR2. Sections 
were then blocked for 1 hour at room temperature with 10% normal goat serum (Gibco) 
and 0.1% triton in PBS.  Primary antibodies against ARX (rabbit, gift kindly provided by 
Professor Kunio Kitamura, 1:500), KI67 (rabbit, Immunological Sciences, 1:300 and 
mouse, BD Pharmingen, 1:200), BrdU (rat, Accurate Chemical and Scientific, 1:200), 
PH3 (rabbit, Chemicon, 1:100), TBR2 (rabbit, Abcam, 1:200 and Chemicon, 1:300), 
PAX6 (mouse, Developmental Studies Hybridoma Bank, 1:1000), CUX1 (rabbit, Santa 
Cruz Biotechnology, 1:50), SATB2 (mouse, Bio Matrix Research, 1:200), CTIP2 (rat, 
Abcam and Beckton-Dickinson 1:300), GFP (chicken, 1:2000), Caspase3 (rabbit, Cell 
Signaling, 1:200), and TBR1 (rabbit, Abcam, 1:25 and Chemicon, 1:400) were diluted in 
10% normal goat serum and incubated on slides overnight at 4 °C.  Secondary antibodies 
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were conjugates of Alexa Fluor 488, Alexa Fluor 594, and Alexa Fluor 647 (1:500, 
Invitrogen), biotinylated goat anti-mouse and anti-rabbit (Dako, 1:100).  They were 
diluted in 10% normal goat serum and incubated on slides for 2 hours at room 
temperature.  Biotinylated secondary antibodies were subsequently incubated with 
strepdavidin-Cy3 (Jackson ImmunoResearch, 1:300) in PBS.  Slides were then 
counterstained with DAPI (Invitrogen, 1:1000), washed and mounted in Fluorescent 
Mounting Medium (DakoCytomation). 
For the ARX/TBR2 double labeling, sections were blocked in 10% normal 
donkey serum (Jackson ImmunoResearch) with 0.3% triton in TBS (Tris buffered saline 
pH 7.4, USB Cleveland, OH; the buffer used throughout the procedure) for 30 minutes at 
room temperature. Anti-TBR2 antibody (Abcam, 1:200) in 10% donkey serum next was 
applied for 2 hours at room temperature followed by washing with TBS and then 
incubation with goat anti-rabbit monoclonal Fab fragments (Jackson ImmunoResearch, 
1:25) in 10% donkey serum for 30 minutes at room temperature.  They were then washed 
and secondary Alexa 594 donkey anti-goat 1:200 in 10% donkey serum in TBS was 
applied for 30 minutes at room temperature.  For the second primary antibody the 
sections were again washed and blocked with the goat anti-rabbit monoclonal Fab 
fragments 1:25 in 10% donkey serum.  After washing the anti-ARX antibody was applied 
overnight at 4 °C in 10% donkey serum.  Finally the slides were washed and the 
secondary Alexa 488 donkey anti rabbit was applied at 1:200 in 10% donkey serum for 
30 minutes at room temperature.  The slides went through on final wash, were 
counterstained with DAPI and mounted.  
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Quantifications and statistical analysis 
All quantifications on P14 cryostat brain sections were performed using a 200µm 
section of the dorsomedial cortex at the mid-hemispheric level from pia to white matter.  
For quantifications on E11.5 and P1 brain sections, cell counts were derived from 25% of 
the neocortex.  The area of interest was derived by measuring the linear distance along 
the pial and ventricular surfaces of the entire lateral cortex, dividing those into quarters, 
and then using the total area, from pia to ventricle, in the third quartile from the dorsal 
midline.  Quantifications on E14.5 brain sections were performed using a 150µm section 
of the dorsomedial and lateral cortex.  At least three serial sections from three different 
animals for each genotype were photographed using a Leica DMR fluorescent 
microscope.  Images were imported into Photoshop CS3 and double-positive cells were 
overlaid manually by color-coded dots in new layers.  The number of labeled cells (dots) 
was calculated using the Record measurements of Photoshop CS3 and imported into 
Excel 2008.  The percentage of labeled cells per region per section was calculated for 
each brain, and the final mean percentage calculated across all brains.  Results were 
expressed as mean value ± SD and were tested for statistical significance by the two 
tailed, unpaired Student's t test  (p < 0.05 level of significance). 
RNA isolation, processing, and microarray analysis 
The experiment was performed as previously described (Colasante G et al. 2009).  
Briefly, 3 pregnant Arx heterozygous dams crossed with C57Bl/6 males were sacrificed 
at E14.5.  A total of 5 wt and 5 Arx KO embryos were harvested and after brain isolation 
the cerebral cortices were separated from the ventral telencephalon.  Total RNA was 
extracted from the cortices using the Qiagen RNA micro kit (Qiagen, Valencia, CA).  
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cRNAs were generated and hybridized on a total of ten different MOE430v2 Affymetrix 
DNA chips according to the Affymetrix protocol.  The chips were scanned with an 
Affymetrix scanner to generate digitized image data files.  The data were deposited in the 
NCBI Gene Expression Omnibus (Edgar R, Domrachev M, Lash AE. Gene Expression 
Omnibus: NCBI gene expression and hybridization array data repository.  Nucleic Acids 
Res. 2002; 30:207–10) and are accessible through GEO Series (# GSE12956). 
Luciferase reporter assays 
P19 cells (105) were seeded and transfected 24 h after plating with 400 ng of each 
of the following constructs in different combinations: pT81 luciferase reporter plasmids, 
control plasmid pCAG-iresGFP, pCAGArx-iresGFP, pCDNA3-Tle1 and 80 ng of pRL-
TK-Renilla luciferase plasmid DNA (Promega) using Lipofectamine PLUSTM Reagent 
(Roche Diagnostics, Alameda, CA).  Forty-eight hours post-transfection, cell lysis and 
measurement of firefly and Renilla luciferase activity was performed using the Dual-Glo 
Luciferase Assay System (Promega) according to the manufacturer’s instructions.  The 
firefly luciferase activity was normalized according to the corresponding Renilla 
luciferase activity, and luciferase activity was reported as mean relative to pCAG-
iresGFP/luciferase transfection.  The two Cdkn1c -549/-68 and -1490/-720 enhancer 
regions were PCR amplified from E14.5 mouse genomic DNA using the following 
primers: HindIII-Cdkn1c-F1 5’- CCCAAGCTTGCGCGCGGGCCTCCTCAC-3’; 
BamHI-Cdkn1c-R1 5’-CGCGGATCCCCAGGACCAGGACCCAGCTG-3’; HindIII-
Cdkn1c-F2 5’- CCCAAGCTTGAGATCTAAAAGATCTGTAG-3’ and BamHI-Cdkn1c-
R2 CGCGGATCCTAGTGAATGAGGGGTTCATG-3’, respectively.  The amplified 
products were cut with HindIII and BamHI and cloned into the BamHI and HindIII sites 
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of pT81-TK-Luciferase, which contains the thymidine kinase minimal promoter upstream 
of luciferase.  The (-549/-68) enhancer region carrying mutagenized ARX binding site 
was generated by site-directed mutagenesis with the following primers 5’-
CTGAAAATACTACAGGATGCTCCTCGTGAGGAG-3’ and 5’-
CTCCTCACGAGGAGCATCCTGTAGTATTTTCAG-3’ using the QuikChange II site-
directed Mutagenesis Kit (Stratagene), according to the manufacturer’s instructions. 
Chromatin immunoprecipitation 
E14.5 mouse embryonic cortices were isolated and single-cell suspension derived 
by enzymatic treatment.  Cells were cross-linked with 1% formaldehyde for 10 min and 
chromatin prepared essentially as described previously (Ferrai C et al. 2007; Colasante G 
et al. 2008).  The chromatin aliquots (1 ml) were incubated overnight with 1 µg of anti-
GFP (Chemicon) as mock and anti-ARX(C-14) (Santa Cruz).  PCR primers used are the 
following: PCR primers used are the following:  ChIPEbf3-F, 5′-
GTCTATAAGTACAATGGTGACAC-3′; ChIPEbf3-R, 5′-
CTCCATCAAGATCCTTCTC-3′ (amplification product, 240 bp); ChIPCdkn1c-F, 5′-
GCGCCCCTTTATACGCGCTG 3′; ChIPCdkn1c-R, 5′-
TCACGTTACCGCCCGCAGAG-3′ (amplification product 200 bp); ChIPCdkn1a-F 5’-
GCTGTCAAAACGACCTTGAATG-3’; ChIPCdkn1a-R: 5’-
GGAAGGACTAACTCTTTTCCAG-3’ (amplification product 220 bp); ChIPCdkn1b-F 
5’-CCCTGATAAGAGCGGTCAGTC-3’; ChIPCdkn1b-R 5’-
TTACGGAGCTTCGGTGGCTAG-3’ (amplification product 250 bp).  PCR products 
were analyzed on 2% agarose gels in TBE buffer. 
 
  28 
Results  
 
Reduced cerebral cortex and olfactory bulbs after deletion of Arx from the dorsal 
telencephalon  
The germline loss of Arx in mice results in a thinner and disorganized cortex that 
was attributed to a primary defect in cell proliferation (Kitamura K et al. 2002).  To 
further define the role of Arx in cortical progenitor cell proliferation we conditionally 
deleted Arx from the E9.5 dorsal telencephalon by crossing our Arxfl/+ mice to Emx1Cre 
mice (Jin XL et al. 2000) (Fig. 1A, B).  In Arxfl/y; Emx1Cre mice (here after Arx cKO) no 
ARX protein was observed in the VZ and SVZ of the cortex by E11.5 and throughout the 
rest of development (Fig. 1A, B and data not shown).  Morphological analyses performed 
at E14.5 revealed that, at this developmental stage, alterations of the gross morphology of 
Arx cKO brains are already evident.  The cerebral hemispheres are reduced in size and 
the olfactory bulbs are smaller and characterized by an abnormally wide interspace 
separating them (Fig. 1C, D).  Nissl staining on E14.5 coronal sections highlighted the 
diminution of cortical thickness affecting Arx cKO cerebral cortex in its whole medio-
lateral extension (E14.5 relative volume (rv) Arx cKO/ctrl = 0.86±0.03; n=3, p < 0.005 
(Fig. 1E, F, O).  Arx-/y mice die perinatally (Kitamura K et al. 2002; Collombat P et al. 
2003), whereas crosses between Arxfl/+ female and Emx1Cre male mice recovered all 
expected genotypes in Mendelian ratios (data not shown).  Morphological assessments at 
P30 of Arx cKO and relative control brains confirmed the analysis made at E14.5.  
Indeed, the cerebral hemispheres and olfactory bulbs in Arx cKO mice are reduced in 
size, whereas the cerebellum and the brain stem do not appear to be affected (Fig. 1I, J).  
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In addition, P30 Nissl stained coronal sections highlight an overall reduction of the 
cerebral cortex, most evident at the level of pyriform cortex and the hippocampus (rv P30 
= 0.84±0.05; n=3, p < 0.005) (Fig 1K, L, O).  
In the Arx cKO the laminar structure cannot be clearly delineated (Fig. 1M, N) 
and the corpus callosum was absent in Arx cKO brains (Fig. 1P, Q); this feature, together 
with the microcephaly, strongly resembles the morphologic abnormalities observed in 
patients with the XLAG syndrome (Kitamura K et al. 2002). 
Our data indicate the loss of Arx in cortical progenitors recapitulates the 
morphologic defects observed with the germline loss of Arx.  These data support the 
model by which the reduced brain size observed in Arx KO mice and children with loss 
of function ARX mutations, is largely or completely due to a loss of Arx in cortical 
progenitor cells. 
Loss of Arx in the pallial progenitor cells reduces the proliferation rate of cortical 
progenitor cells  
Previous data suggested a decrease in cortical progenitor cell proliferation as the 
basis for the reduced cerebral cortical thickness in Arx KO mice (Kitamura K et al. 2002).  
At E11.5 in cortical development there are similar numbers of progenitor cells in wild 
type and Arx cKO mice cortices as measured by the number of KI67 positive cells (ctrl: 
392±33.5; cKO: 368±45.5, n=3, p=0.579: cells counted in 25% of the cortex from 
ventricular to pial surface)(data not shown).  This suggests normal numbers of cortical 
progenitor cells exist early in development when the progenitor cells are being produced.  
However, when the same analysis was performed at E12.5 we observed a reduction in the 
percentage of proliferating progenitor cells (% KI67+/Hoechst, ctrl: 96.65±2.90; cKO: 
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87.49%±5.58, n=6, p=0.016, cells counted in a 150 µm bin from the ventricular to the 
pial surface)(Fig. 2C-D’, G) and an increase in ßIII-tubulin positive young neurons in Arx 
cKO compared to control (% TUBB3+/Hoechst, ctrl: 10.88±2.96; cKO: 20.75±3.39, n=6, 
p=0.003) (Fig. 2A-B’, H). 
At E14.5 the cortical plate was already thinner (Fig. 1E, F) and the reduction in 
the total number of proliferative cells was more evident in Arx cKO cortices (Fig. 3A, C) 
(ctrl: 259±21.8; cKO: 202.5±16.3; n=6, p < 0.001, cells counted in a 150 µm bin from the 
ventricular to the pial surface).  Moreover, both the types of cortical progenitor cells - 
RGCs and IPCs- are diminished in Arx cKO cortices at this embryonic stage.  Indeed, we 
observed a reduced PAX6 labeling intensity in Arx cKO mice (Fig. 3D’, E’) in addition 
to a 27% reduction in the number of PAX6+ cells (ctrl: 323.6 ± 13.3; cKO: 237.5 ± 26.8; 
n=3, p< 0.001; Fig. 3J) as well as a 20 % reduction of TBR2+ cells (ctrl: 223.6±16.4; 
cKO: 179.3±10.8; n=3, p< 0.001)(Fig. 3F’, G’). 
In order to exclude a contribution of an increase in cell-death to the reduction of 
cortical thickness in Arx cKO cortices, the apoptotic marker Caspase3 was analyzed at 
different embryonic stages (E13.5, E15.5, E17.5), finding no difference between Arx 
cKO and relative controls (Fig. 4). 
To determine if the reduction in proliferation was affecting both types of cortical 
progenitor cells- RGCs and IPCs- in the same way, their rate of BrdU incorporation was 
measured in control and Arx cKO cerebral cortices after a 1 hour BrdU pulse.  As 
expected, general reduction in BrdU incorporation (~24%) (arrows in Fig. 3F’’), was 
found in Arx cKO cortices with respect to controls (ctrl: 142.3 ± 18.2; cKO: 109.0 ± 10.2; 
n=3, p< 0.001 and Fig. 3J).  Interestingly, double labeling with PAX6 and BrdU revealed 
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little differences in the PAX6+/BrdU+ cell number between Arx cKO and control (ctrl: 
125.6±19; cKO: 103.7±7.17; in both cases about 40% of the total PAX6+ cells; n=3, 
p=0.012)(Fig. 3D’’’, E’’’, J).  Conversely, double labeling with TBR2 and BrdU revealed 
a reduction of dual labeled cells (ctrl: 52.9 ± 12.9, about 25% of the total TBR2+; cKO: 
17.5 ± 2.9, about 10% of the total TBR2+; n=3, p< 0.001)(arrows in Fig. 3F’’’, G’’’, J).  
Consistent with these data, staining with the M-phase marker phosphohistone 3 (PH3) 
revealed an overall reduction of positive cells in the Arx cKO cerebral cortex with a 
greater loss in the basal area (IPCs) than the apical area (RGCs) (apical, ctrl: 122.0 ± 5.6, 
cKO: 107.5 ± 3.5; basal, ctrl: 39.0 ± 4.8; cKO: 11.5 ± 2.12 n=3, p< 0.001, Fig. 3H, I, H’, 
I’, J).   
Taken together, these data indicate that at E14.5 both progenitor populations 
(RGCs and IPCs) are reduced in Arx cKO cerebral cortices and their proliferation is 
affected.  However, BrdU incorporation rates and PH3 staining indicate that there is a 
disproportionate deficit in the proliferation of IPCs compared to RGCs in Arx cKO mice.   
Cortical progenitors show a normal cell cycle length, but IPC mitoses are strongly 
reduced in Arx cKO mice. 
To further understand the mechanism by which loss of Arx resulted in fewer 
proliferating cells, we tested two non-mutually exclusive hypotheses: that the cell cycle 
changes are related to lengthening of the cell cycle or to precocious exit of cortical 
progenitors from the cell cycle.  
An increased cell cycle length during the neurogenic period would result in fewer 
cellular divisions, fewer progenitor cells and the observed reduction in BrdU 
incorporation.  To examine neocortical cell cycle dynamics in the absence of Arx the 
  32 
length of the cell cycle phases was estimated between E13.5 and E14.5 in wild type and 
Arx cKO mice using a cumulative BrdU pulse-labeling paradigm (Takahashi T et al. 
1995).  BrdU was injected intraperitoneally in gravid mothers every 3 hours up to 6 time 
points with survival time being 0.5 hour after the last injection.  At least 2 brains of each 
genotype were assayed at each time point for BrdU labeling to evaluate the cell cycle 
parameters in the VZ precursors, where VZ was defined by two criteria: the region under 
the area with high density of TBR2+ cells and where cells with vertically oriented nuclei 
were present.  Moreover TBR2/BrdU double staining was performed in order to gain 
information regarding the BrdU incorporation kinetic of IPCs.  Representative cortical 
fields of control and Arx cKO BrdU and TBR2 labeled coronal sections are shown for 5 
out the 6 time points (Fig. 5A-J).  
The growth fraction (GF) in the VZ - defined as the maximum percentage of VZ 
progenitors entering the S-phase on the total of nuclei in the VZ - did not change between 
the two genotypes, and in both cases almost 100% of VZ cells were BrdU+ at the 9.5 h 
time point (Fig. 5G, H).  The Labeling Index (LI) of VZ (BrdU+cells/total cell number) at 
each time point was plotted against the corresponding time after BrdU injection and from 
the slope of the interpolating lines, the cell cycle parameters Tc and Ts were calculated 
(Fig. 5N, P).  Interestingly, no significant difference was found in both parameters 
between control and Arx cKO brains (ctrl: Tc=14.5 hrs and Ts= 4 hrs; cKO: Tc=14.1 hrs 
and Ts= 4.1 hrs). 
A similar analysis of the cell cycle kinetic was performed in the SVZ.  First, the 
GF at E13.5 was evaluated as the percentage of proliferating IPC (KI67+ TBR2+) on the 
total of IPCs (TBR2+) (Fig. 5K-L’).  Interestingly, while about the 75% of IPCs in the 
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control were proliferating, only the 45% of cKO IPCs entered any cell cycle phase (% 
KI67+ TBR2+/TBR2, ctrl: 74.30±1.99; cKO: 45.17±2.64, n=4, p<0.0004).  Similar 
reduction in the SVZ GF of Arx cKO was noticed also later on during cortical 
development (Fig. 6; E17.5 % KI67+ TBR2+/TBR2, ctrl: 16.57±2.49; cKO: 7.58±0.26).  
This result confirmed and completed the previous observations relative only to S and M 
phases of the cell cycle. 
Then, LI in the SVZ was calculated as the ratio between the TBR2+ cells 
incorporating BrdU on the total of TBR2+ proliferating cells (BrdU+ TBR2+/Ki67+ 
TBR2+) and plotted against the corresponding time after BrdU injection and interpolating 
lines generated for both control and Arx cKO (Fig. 5A’’-J’’, O).  The slope of the Arx 
cKO interpolating line resulted slightly higher, indeed cKO IPCs seemed to reach the 
value of GF=1 a little before the control (Tc-Ts, control: 7.8h; cKO: 6.3h).  As a 
consequence, Tc and Ts resulted a little bit shorter in cKO IPCs with respect to control 
(Fig. 5P).  The ratio between Ts and Tc was not significantly altered (Ts/Tc, ctrl: 0.25; 
cKO: 0.24), suggesting that the relative length of the different cell cycle phases was 
constant.  
Interestingly, the same conclusions were reached by a different approach.  We 
measured the BrdU labeling index (0.5 hour pulse) in SVZ precursors (Ki67+) at E14.5 
(Arnold SJ et al. 2008), finding significant decrease in the number of proliferating Ki67+ 
cells/100 µm2 area in cKO SVZ with respect to control (ctrl: 19.83 ± 6.04 and cKO: 3.83 
± 1.94; n=4, p<0.005; Fig. 7A, B, C), comparable to the reduction in BrdU+ (Fig. 8) and 
PH3+ cells in cKO SVZ (Fig. 3J).  Consequently, the ratio between the number of S-
phase cells (BrdU+) and the total of those proliferating (Ki67+) showed no significant 
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difference (ctrl: 0.44 ± 0.02 and cKO: 0.40 ± 0.10; n=4, p=0.34; Fig. 8C).  This last set of 
data again indicates that Ts/Tc ratio of Arx cKO SVZ precursors is comparable to control.  
Consequently, the reduced BrdU incorporation observed in cumulative labeling 
experiment of TBR2+ cells can be attributed to a consistent reduction in the proliferation 
ability of Arx cKO SVZ progenitors and not to an alteration of their cell cycle length. 
Precocious cell cycle exit in Arx cKO cortical progenitors 
Since only about half of the pool of IPCs is able to proliferate in Arx cKO cortex, 
we predicted precocious cell cycle exit of these cells.  Thus, we assessed the fraction of 
cells exciting the cell cycle 24 hours after a BrdU pulse (between E13.5 and E14.5).  
Cells remaining in the cycle are BrdU+/Ki67+, while those that have stopped cycling 
exhibit BrdU labeling only (Chenn A and CA Walsh 2002).  At E13.5, an increase of 
18% in the cells leaving the cycle is observed in Arx cKO progenitors (leaving fraction in 
ctrl: 0.49±0.06; in cKO: 0.58±0.05; n=8 for each, p <0.0005; Fig. 7A’’, B’’, C) 
suggesting precocious neurogenesis.  Consistent with that, more cells with undiluted 
BrdU exist in the Arx cKO when compared to control (arrowheads, Fig. 7A’, B’).  
Although it is not possible to distinguish the contribution of RG cells and IPCs to the 
fraction of precociously differentiating cells, it is likely that most of those cells are IPCs, 
that may exit cell cycle without any round of amplification. 
In order to evaluate the effects of IPC reduced proliferation in Arx cKO, we 
analyzed GFP expression in E15.5 Arx cKO and relative control mice crossed with 
Tbr2::GFP transgenic animals (Fig. 7D, E, D’ E’),  where GFP is under the control of the 
Tbr2 endogenous regulatory sequences (Kwon GS and AK Hadjantonakis 2007).  Due to 
the stability of the GFP protein in vivo, GFP fluorescence in Tbr2::GFP mice can be used 
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as a lineage tracer of the IPC progeny (Sessa A et al. 2008).  We noticed an overall 
decrease in GFP+ cells in Arx cKO SVZ and cortical plate with respect to control 
consistent with a reduction in the amplification of IPCs in the cKO (GFP+ cells/150 um 
area unit, ctrl: SVZ, 55.7±5.13; IZ, 80.00±16.7; CP, 180.33±6.51; total, 316.00±15.39; 
cKO: SVZ, 27.70±7.37; IZ, 63.33±26.63; CP, 83.00±2.64; total 181.70± 21.01; n=4 
p<0.005 (Fig. 7F). 
Given the more pronounced effect of Arx ablation on IPCs than on RGCs, we 
sought to assess if Arx is also expressed in IPCs in addition to RGCs (Friocourt G et al. 
2006).  We performed immunofluorescence for ARX and TBR2 in wild type cortex at 
E14.5 and showed that ARX colocalizes with TBR2 in many cells of the VZ/SVZ  (Fig. 
9).  
Arx cKO mice have a reduced number of upper cortical layer neurons with normal 
numbers of deeper layer neurons 
In order to determine if the reduced proliferation of cortical progenitors has an 
effect on cortical lamination, we evaluated molecular markers of cortical layers at 
different developmental stages.  First, the expression of TBR1 - labeling neurons in 
subplate, layer VI and few in layer V (Molyneaux BJ et al. 2007)- was evaluated in 
control and Arx cKO mice at E16.5.  In Arx cKO the number of TBR1+ cells in layers V-
VI was slightly decreased with respect to control (TBR1, ctrl layer V-VI= 98.2±6.5; cKO 
layer V-VI=82.0±7.8)(Fig. 10A, B).  Interestingly, more neurons were found in Arx cKO 
subplate, still detectable at this stage (TBR1, ctrl: SP=36.5±4.5; cKO: SP=60.0±3.5) 
(arrowheads in Fig. 10A, B).  
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A similar difference, although more dramatic, was observed staining for CTIP2, 
which labels predominately layer V, but also layer VI neurons (Molyneaux BJ et al. 
2007).  CTIP2+ cells are already well organized in control layers V-VI, with some 
positive cells localized in the subplate, whereas in the Arx cKO they appear less compact 
and completely disorganized (arrowheads in Fig. 10C, D).  However, the total number of 
CTIP2+ cells does not change between Arx cKO and control (CTIP2, ctrl: 166.9±4.2 and 
cKO: 155.7±5.7)(Fig. 10U).  In order to assess upper layer stratification, we then used P1 
and P14 animals.  At P1 Arx cKO mice had a decreased number of cells labeled with 
SATB2 in layer II/III in the Arx cKO cortices with respect to controls (SATB2 ctrl: layer 
II/II= 131.4±18.5 and SATB2 cKO: layer II/III= 96.9±12.6; n=5, p=0.0126)(Fig. 10I, J), 
but not in layer IV/V (SATB2 ctrl: layer IV/V=84.0±6.8 and SATB2 cKO: layer IV/V= 
77.9±7.6; n=5, p=0.547)(Fig. 10I, J).  In addition, the number of cells labeled with 
CUX1, a marker of layer II-IV, is also decreased in the Arx cKO cortices (CUX1 ctrl: 
layer II-IV= 125.9±7.0 and CUX1 cKO: layer II-IV= 95.9±7.8; n=5, p=0.0327) (Fig. 10I-
L).  However, no significant difference between the Arx cKO and control cortices was 
detected for layer V and VI markers (CTIP2 ctrl: total= 97.5±7.5 and CTIP2 cKO: total= 
93.2±9.6; n=3, p=0.587; TBR1 ctrl: total= 116.9±4.9 and TBR1 cKO: total= 92.1±14.2; 
n=3, p=0.132) (Fig. 10E- H).  
At P14, a time in which laminar organization is complete, a decrease in the 
number of SATB2 and CUX1 positive cells persisted in layer II/III in the Arx cKO 
cortices when compared to control cortices (SATB2 ctrl: layer II/II= 29.5±2.4 layer IV= 
41.4±3.8 and SATB2 cKO: layer II/III= 21.2±3.9 layer IV= 24.5±3.0; n=4, p=0.0286; 
CUX1 ctrl: layer II-IV= 30.5±2.1 and CUX1 cKO: layer II-IV= 24.9±3.5; n=4, 
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p=0.0482)(Fig. 10Q-T).  However, similar numbers of CTIP2 positive and TBR1 positive 
cells are present in the Arx cKO cortices as compared to control (CTIP2 ctrl: total= 
35.5±3.7 and CTIP2 cKO: total= 29.2±1.7, n=3, p=0.272; TBR1 ctrl: total= 32.7±2.1 and 
TBR1 cKO: total= 32.5±2.5, n=3, p=0.406)(Fig. 10M-P). 
In summary, we find a reduction of upper layers (II-IV) neurons with no change 
in deeper layer (V-VI) neurons in Arx cKO mice.  
Identification of genes differentially expressed in Arx KO versus wild type cerebral 
cortex by transcriptome analysis 
To gain insight into the Arx-dependent mechanism responsible for the reduced 
proliferation in Arx cKO cortical progenitor cells observed at E14.5, we performed a gene 
expression profile analysis.  Since all the proliferation defects observed in the Arx cKO 
cortices were also detected in Arx KO mouse model (data not shown), we decided to 
perform this experiment in Arx KO dorsal telencephalon.  E14.5 embryonic stage was 
selected for analysis, as the proliferation defect was clearly detectable.  Brains were 
harvested and the cerebral cortices were carefully dissected and processed for gene 
expression profiling (Fig. 11) RNA was separately extracted from the isolated tissues and 
used to hybridize Affymetrix microarrays (MOE430v2) containing 45,101 probe sets.  
Cortical tissues from Arx KO (n = 5) and control (n = 5) embryos were independently 
processed on 10 different gene-chips in order to minimize individual biological 
differences.  Data sets obtained were then used to identify differentially expressed 
transcripts between Arx KO and wild type dorsal telencephali (Fig. 11A-I). 
Using a log2 (fold-change ≥ 1 and a FDR ≤ 0.05) linear model, the analysis 
revealed that a total of 147 probe sets corresponding to 86 different Entrez Gene 
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Identifiers presented significantly different expressions between Arx KO and wild type 
cortices (Fig. 11A-I). 
Among the full set of identified genes, 3 (DDX3Y, KDM5D and EIF2S3Y) (Fig. 
6I) were considered as Arx-independently misregulated.  In fact, they correspond to Y-
linked expressing units and their upregulation in Arx KO tissues is indicative of a sex-
biased harvest of the embryos.  This was expected because all Arx KO embryos were 
males (Arx−/Y), while wild type embryos displayed an equal probability to be males or 
females.  The remaining 83 differentially expressed genes were grouped according to the 
known or predicted protein function they coded for: transcription factors (Fig. 11A); 
receptors (Fig. 11B); intracellular regulatory proteins (Fig. 11C); structural proteins (Fig. 
11D); extracellular regulatory proteins (Fig. 11E); extracellular junctions and adhesion 
molecules (Fig. 11F); carriers and transporters (Fig. 11G); extracellular matrix proteins 
(Fig. 11H).  
To ensure the reliability of our analysis, some of the misregulated genes were 
selected and analyzed in control and KO tissues using quantitative real-time RT-PCRs 
(qPCRs).  In this experiment, only RNA extracted from male control embryos was used, 
in order to avoid any sex biased gene expression between males and females (Yang F et 
al. 2006). 
In all cases analyzed, qPCR results confirmed previous gene-array analyses both 
for the up-regulated genes RARb, Id1, Id3, Tub6, Olig2, and Cdkn1c as well as the down-
regulated Pax6 gene (Fig. 11J, all normalized to ß-actin).  However, the magnitude of the 
changes in expression levels detected by qPCRs was, in some cases, significantly higher 
(up to 2.5 fold) when compared to the microarray analyses (RARb, Olig2, Cdkn1c), while, 
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in other instances, the results were comparable (Id1, Tub6, Pax6).  Interestingly, the 
expression of Tbr2 was found decreased in Arx KO compared to control (20% reduction) 
in agreement with our immunohistochemistry data, even if the microarray analysis didn’t 
show any significant alteration. 
Cdkn1c is overexpressed in Arx KO cerebral cortex 
Among the genes found to be misexpressed in Arx KO cerebral cortices, we 
noticed the upregulation of Cdkn1c.  Cdkn1c encodes for CDKN1C (also known as 
p57/KIP2), a member of the Cip/Kip family of cyclin dipendent kinase inhibitors (CKIs).  
Together with the two other members of this family, CDKN1A and CDKN1B, it exerts a 
basilar role in the regulation of cell cycle progression of cortical progenitors at level of 
G1/S transition by inhibiting the cyclin/CDK complexes (Sherr CJ and JM Roberts 
1999).  Recently, Mairet-Coello and colleagues showed that CDKN1C overexpression in 
the cerebral cortex elicits precursor cell cycle exit and promotes transition from 
proliferation to neuronal differentiation, while opposite effects occur in CDKN1C-
deficient precursors.  Indeed, they reported that in mutant mice proliferation of radial 
glial cells (RGC) and intermediate precursors (IPC) was increased, expanding both 
populations, with greater effect on IPCs (Mairet-Coello G et al. 2012). 
As this function is particularly consistent with the phenotype observed in Arx 
cKO brains and might underlie the reduction in the cerebral cortex volume, we focused 
further analyses on this gene.  
  In order to ascertain if Cdkn1c misregulation plays a role in Arx KO tissues, we 
first assessed its expression by in situ hybridization throughout embryonic development 
(E12.5-E18.5) in wild type and Arx KO mouse brain sections (Fig. 12A, B, D, E and Fig. 
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13).  The expression of Arx was evaluated on adjacent wild type brain sections (Fig. 12C, 
F and Fig. 13).  At E12.5 Cdkn1c transcript was barely detectable in the SVZ of control 
cortices whereas it was significantly overexpressed in both VZ and SVZ of Arx KO (Fig. 
12A, B, arrowheads A’, B’).  Interestingly, the upregulation of Cdkn1c seemed to follow 
a gradient in Arx KO cortices, higher lateral-lower medial (Fig. 12B).  Similarly, at 
E14.5, Cdkn1c is still expressed in the SVZ in control tissues (Fig. 12D, arrowheads D’) 
and overexpression persists in Arx KO cortices (Fig. 12E, arrowheads E’).  In contrast to 
E12.5, Cdkn1c expression clearly followed a higher medial-lower lateral gradient in both 
control and KO cortices (Fig. 12D, E).  Beginning on E16.5, Cdkn1c transcript was 
additionally detected in cortical plate cells of both control and KO brains and at E18.5 the 
level of Cdkn1c up-regulation in Arx KO cortices was significantly diminished, inversely 
correlating with the Arx expression pattern at the same developmental stages (Fig. 13).  
Similar results were also observed in Arx cKO cortices.  
Unexpectedly, although Arx is strongly expressed in the ganglionic eminences, in 
particular at E12.5, E14.5 and E16.5 (Fig. 12C, F and Fig. 13), its ablation in Arx KO 
mice does not induce Cdkn1c up-regulation in this compartment (Fig. 12B, E and Fig. 
13). 
In conclusion, our expression analysis of Cdkn1c in wild type and Arx KO 
cerebral cortices throughout the neurogenic period, showed that this gene is upregulated 
in Arx KO cortical VZ and SVZ, with a pattern that parallels Arx expression in control 
tissues.  Thus, this correlation raises the possibility that Arx depletion directly promotes 
Cdkn1c upregulation in cKO tissues.  
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Cdkn1c is a direct transcriptional target of ARX 
To determine if Cdkn1c is a direct transcriptional target of ARX, a 5 kb genomic 
region upstream to the murine Cdkn1c gene locus was screened for the presence of 
putative ARX binding sites.  Previous studies identified palindromic sequences 
TAAT/ATTA spaced by 3 nucleotides (5’-ATTANNNTAAT-3’) as favored binding sites 
for paired homeodomain proteins (Wilson D et al. 1993).  Indeed, our search highlighted 
the presence of a unique palindromic sequence (5’-ATTAGCATAAT-3’) located 
between bases -71/-81 upstream of the Cdkn1c transcription start site (named +1) (Fig. 
12G).  As binding sites for transcriptional regulators are usually evolutionary conserved, 
we performed a multiple alignment of the aforementioned genomic region among 
different species, finding a high level of conservation in the ARX putative binding site in 
mouse, rat, human and orangutan, except for the 3 spacing nucleotides that were not 
conserved in orangutan (Fig. 12G).  A genomic region of approximately 500 bp (-549/-
68) containing the putative ARX binding site and another of about 750 bp (-1490/-720 
containing some TA repeats, were separately cloned, upstream to a minimal promoter, in 
a construct containing the Luciferase gene and tested for transcriptional reporter activity 
(Fig. 12H).  The 500 bp (-549/-68)-Luc and 750 bp (-1490/-720)-Luc constructs were 
separately co-transfected with control plasmid pCAG-IRESGFP or pCAGArx-IRESGFP 
in P19 cells and the effect of ARX expression on the basal transcriptional activity of the 
two putative regulative sequences was evaluated.  ARX co-transfection reduced the basal 
transcriptional activity of the 500 bp regulative region by 30% (fold increase/decrease in 
transcriptional activity of pCAG-ArxIRESGFP coinfected with respect to pCAG-
IRESGFP coinfected: 0.67±0.04; n=3, p<0.005).  However, higher reduction was 
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detected when the corepressor Tle1 (McKenzie O et al. 2007) was cotransfected in 
association with ARX (0.42±0.06, n=3, p<0.005).  Surprisingly, ARX and in particular 
TLE1 alone are able to repress luciferase transcription; this is due to the fact that both 
proteins are already expressed at low levels in P19 cells (data not shown).  Conversely, 
when pCAG-ArxIRESGFP was cotransfected with the Luciferase construct regulated by 
750 bp enhancer, only a slight reduction in the basal transcriptional activity was assessed 
(fold increase/decrease in transcriptional activity of pCAG-ArxIRESGFP coinfected with 
respect to pCAG-IRESGFP coinfected (transcriptional activity; 0.94± 0.01, n=3, 
p<0.05,), even in combination with TLE1 (Fig. 12H).  When the binding site 5’-
ATTAGCATAAT-3’ was mutagenized to 5’-AGGAGCATCCT-3’, no significant 
reduction in Luciferase expression was appreciated in cotransfection experiments (Fig. 
12H).  
These results indicate that ARX exerts a specific transcriptional repression 
activity on this 500 bp (-549/-68) genomic region; in order to assess if this repression is 
direct or mediated by other factors expressed in P19 cells we performed chromatin 
immunoprecipitation experiments.  Anti-ARX antibody was used to immunoprecipitate 
chromatin isolated from E14.5 telencephali; then, PCR amplification reactions, with 
primers designed to span the 500 bp (-549/-68) region upstream to Cdkn1c gene, allowed 
us to evaluate an enrichment of that region in the ARX immunoprecipitated chromatin 
with respect to IgG only and anti-GFP immunoprecipitated chromatin (Fig. 12I).  
Amplifications with primers spanning Ebf3 regulatory region were also performed and 
used as a positive control, as Ebf3 was previously showed to be a direct target of ARX in 
the ventral pallium (Fulp et al., 2008).  We found enrichment of the Cdkn1c (and Ebf3) 
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regulatory regions when pulled down with an anti-ARX antibody but not with the anti-
GFP or no antibody controls.  No enrichment in ARX immunoprecipitated chromatin 
samples was detected amplifying for Cdkn1a and Cdkn1b regulative regions (Fig. 12I), as 
expected by the absence of any alteration of the two gene transcripts in Arx KO cortices.  
Taken together, these results suggest that ARX is a direct repressor of Cdkn1c 
transcription and it likely exerts this role by direct interaction with the palindromic 
binding site 5’-ATTAGCATAAT-3’ located in the 500 bp enhancer region. 
 
Discussion 
Loss of ARX/Arx in both humans and mice results in a reduced size of the cerebral 
hemispheres.  In this study, by crossing Arxfl/y mice with Emx1Cre mice, we have 
confirmed that the reduced brain size is largely if not completely due to the loss of Arx in 
cortical progenitor cells.  Indeed, in E14.5 Arx cKO we observed a reduction in the 
number of cortical progenitor cells, both PAX6+ and TBR2+, that might be the result of 
the precocious RG progenitor differentiation observed at E12.5 in Arx cKO.   
However, this cannot be the only underlying mechanism.  In fact, also the 
proliferation rate of cortical progenitor cells is affected in Arx cKO and our data suggest 
that the IPC pool is more affected than the RGC compartment: almost all S-phase 
progenitors in E14.5 Arx cKO cortices are PAX6+ cells and only rarely TBR2+.  
Consistent with this, basal mitoses are dramatically reduced.  Interestingly, the 
determination of the growth fraction at E13.5 allowed us to understand that, whereas all 
the cKO RG progenitors were able to proliferate at that stage, only 45% of TBR2+ cells 
in Arx cKO could enter cell cycle (versus the 75% of the control).  These observations 
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support the hypothesis that the drastic effect on the IPC proliferation is not only due to a 
premature differentiation among VZ progenitors but essentially to a direct effect of ARX 
ablation on IPCs.  In line with this, we found ARX expression in many TBR2+ cells of 
the VZ/SVZ.  
This reduction of cortical progenitor cells led to an alteration of the cortical 
layering: a significant loss of cells from the superficial layers of Arx cKO cerebral cortex 
with relative preservation of the deeper layers.  Our observations in this genetic model 
complement those found after an acute reduction of Arx through the in utero 
electroporation of an Arx shRNA in mid gestation where an increased number of 
progenitors exiting the cell cycle and prematurely adopting the neuronal fate were found 
(Friocourt G et al. 2008). 
We also performed a gene expression profile analysis in wild type and Arx KO 
cerebral cortices that identified 83 misregulated genes.  Interestingly, this analysis found 
very little overlap with the results of the same analysis that we previously performed in 
the ganglionic eminences (Fulp CT et al. 2008; Colasante G et al. 2009).  These data 
reinforce the assertion that ARX exerts region specific roles in the ventral telencephalon 
and in the cerebral cortex through the activation/repression of different transcriptional 
programs (Nasrallah MP et al. 2012).  In agreement with the reduction of GABAergic 
interneurons migrating to the cerebral cortex in Arx KO brains (Kitamura K et al. 2002; 
Colombo E et al. 2007), markers of specific interneuron subclasses (NPY, Somatostatin 
and also LHX6) were downregulated in KOs.  However, among the several misregulated 
genes, we focused our attention on Cdkn1c, as we considered it the most interesting Arx 
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putative target, whose up-regulation could account for the phenotype observed in Arx 
cKO cortices (Mairet-Coello G et al. 2012).  
Our characterization of the Cdkn1c expression pattern during normal 
corticogenesis found Cdkn1c to be expressed in the SVZ in the first phases of 
neurogenesis (E12.5-E14.5).  At later stages it is also detected in the cortical plate (CP).  
Conversely, in Arx cKO, it is strongly upregulated in the VZ and SVZ starting at E12.5.  
The expression of Cdkn1c during corticogenesis has been debated for a long time.  While 
early reports indicated that Cdkn1c mRNA is localized in the VZ, SVZ, and CP of 
embryonic rat cortex (van Lookeren Campagne M and R Gill 1998), CDKN1C protein 
has been localized in the CP, with faint expression in the IZ and no signal in the VZ/SVZ 
(Nguyen L et al. 2006; Itoh Y et al. 2007).  A few recent studies have helped clarify this 
issue (Nguyen L et al. 2006; Tury A et al. 2011; Mairet-Coello G et al. 2012; Tury A et 
al. 2012).  Using an antibody against CDKN1C, they found it is expressed mainly in 
differentiating postmitotic neurons, but also it colocalizes with TBR2+ cells in SVZ and 
with some PAX6+ in VZ.  These data are fully consistent with our data on Cdkn1c 
expression obtained by in situ hybridizations. 
Recently Tury et al. (2011) showed that CDKN1C overexpression in E14.5–15.5 
rat embryos elicits precursor cell cycle exit and promotes transition from proliferation to 
neuronal differentiation.  Comparing the neurogenic and astrogliogenic effects of 
CDKN1B and CDKN1C, they discovered that CDKN1C overexpression promotes more 
neuronal differentiation than CDKN1B (Tury A et al. 2011).  The specific neurogenic 
effect of CDKN1C is particularly interesting in relation to its expression in IPCs, which, 
distinct from RGCs, generate only neurons.  However, they do not clearly analyze the 
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specific effect of CDKN1C overexpression on the two cortical progenitor cell 
populations.  In their follow-up work, Mairet-Coello et al. (2012), analyze the phenotype 
of Cdkn1c mutant mice, finding that proliferation of both RGCs and IPCs is increased, 
expanding both precursors with greater impact on IPCs.  
In this context, our report is the first to describe the effect of CDKN1C 
overexpression on cortical progenitor cell proliferation, integrating the analysis 
previously performed.  Interestingly, our data also support the hypothesis that CDKN1C 
is more relevant for IPC than RGC cell cycle exit, although CDKN1C is overexpressed in 
both cortical VZ and SVZ, the most dramatic effect is observed on IPC and not on RGC 
proliferation.  
We propose a model for the Arx-dependent control of cortical progenitor cell 
proliferation (Fig. 14).  Arx expression in the VZ and partially in the SVZ is able to 
repress Cdkn1c premature expression, allowing proliferation of RGC cells and expansion 
of IPCs.  When Arx is normally downregulated, the consequent up-regulation of 
CDKN1C in the SVZ favors IPC cell cycle exit.  In contrast, in Arx KO cortex, CDKN1C 
expression is high in the VZ resulting in a mild proliferation effect on RGC cells.  More 
dramatic is the impact on TBR2+ IPCs; these progenitors have already such a high level 
of CDKN1C that directly exit the cell cycle without significant cell division. 
Certainly, the presence of other alterations or compensatory mechanisms cannot 
be excluded in Arx cKO cortices.  For example, the microarray analysis highlighted the 
up-regulation of Id1 and Id2 genes in Arx KO cortices.  It is known that their targeted 
disruption in mice results in premature withdrawal of progenitor cells from the cell cycle 
and expression of neural-specific differentiation markers (Lyden D et al. 1999).  Thus, it 
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is likely that their overexpression in Arx cKO cortices might compensate for the Cdkn1c 
up-regulation, mitigating the full phenotypic expression.  Among the compensative 
mechanisms, we could also consider the slight acceleration of cell cycle duration in IPCs 
observed in Arx cKO.  
We also demonstrated that Cdkn1c is a direct transcriptional target of ARX.  The 
genomic region 5’ to the murine Cdkn1c gene locus was screened for the presence of the 
ARX putative binding site and a unique palindromic sequence (5’-ATTAGCATAAT-3’) 
was located a few bases upstream of the Cdkn1c transcription start site.  Luciferase 
assays allowed us to demonstrate that ARX, together with the corepressor TLE1, is able 
to repress transcription through binding at the identified 500bp enhancer region.  
Furthermore, chromatin immunoprecipation revealed that ARX directly binds in this 500 
bp Cdkn1c enhancer region.  
Surprisingly, the ARX binding site that we identified in this study is different 
from the one described in our previous work (Fulp CT et al. 2008).  In that work we 
analyzed the transcription factor binding sites (TFBSs) significantly enriched in the 
regulatory regions of genes whose expression increased within Arx KO subpallium, we 
identified the sequence TAATTA.  In a recent study using the ChIP-chip methodology in 
ARX transfected N2a cells almost 50% of Arx immunoprecipitated sequences N2a cells 
were unequivocally enriched for TAATTA binding site in comparison to controls (Quille 
ML et al. 2011).  In this same study, only 20% of the genes ARX immunoprecipitated in 
E15.5 mouse embryonic brains were found to have this binding site; furthermore, any 
other motif enriched in ARX-bound sequences by comparison to control sequences, could 
not be identified (Quille ML et al. 2011).  These results suggest that whereas 
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overexpressed ARX seems to be recruited primarily to TAATTA, in more physiological 
conditions such as in embryonic brain, ARX is recruited to other less common motifs or 
needs other factors for DNA binding.  Based on these data, the ATTAGCATAAT site we 
identified might be one of the in vivo binding sites to which ARX is recruited.  
Surprisingly, the ChIP on chip analysis performed by Quillé and colleagues revealed that 
ARX binds the Cdkn1a (p21/Cip1) promoter but not Cdkn1c, however this might be due 
to limitations of the ChIP-chip technique.  Indeed, ChIP-seq experiments might allow 
further delineation of ARX direct transcriptional target genes.   
In summary, our data indicate ARX plays a unique role in the progenitor cells of 
the cerebral cortex when compared to its role in the ventral forebrain.  By genetically 
eliminating Arx from pallial progenitor cells we find a reduction in the number of RGC 
due to a premature exit from the cell cycle and significant skipping of the IPC 
amplification stage of corticogenesis.  This defect results in the predicted deficit in upper 
later neurons of the cerebral cortex.  We further elucidated the pathogenesis of this defect 
by identifying the cell cycle regulator CDKN1C as a downstream target of ARX.  Our 
study extends our understanding of the aberrant molecular network responsible for the 
reduced proliferation observed in Arx cKO forebrains; indeed, this is a critical point for 
understanding the pathogenic mechanisms underlying these devastating neurologic 
disorders and in devising genetic or cellular therapeutic strategies to ameliorate Arx 
mutation induced pathological phenotypes. 
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Figure 1: Reduction in cerebral cortex and olfactory bulb dimensions is observed in Arx 
cKO brains. (A, B) At E11.5 ARX expression is lost in the cortical VZ of Arx cKO brains when 
compared to control brains. (C-H) At E14.5 the Arx cKO brains exhibit a reduced size of the 
cerebral hemispheres and the olfactory bulbs (C, D). Nissl stained coronal sections (E, F) and 
corresponding high magnification of the cerebral cortex (G, H) highlight a diminution in the 
cortical thickness in the Arx cKO brains when compared to controls. (I-N) Morphological 
analysis of postnatal (P30) control and Arx cKO brains confirms the previous observations: 
cortical vesicles and olfactory bulbs are under developed, whereas the cerebellum and the brain 
stem do not appear to be affected (I, J); Nissl stained coronal sections reveal an overall reduction 
in the telencephalic structures in Arx cKO brains, involving the cerebral cortex and hippocampus 
(K, L). Magnifications of cortical areas show an increased nuclear density in the deeper layers 
(IV-VI) of Arx cKO compared to controls (M, N). (O) Quantifications of relative cortical volume 
(rv) at E14.5 and P30 of Arx cKO brains compared to controls. Error bars correspond to S.D. (P, 
Q) The corpus callosum is absent in Arx cKO brains. Cx, cortex; Hyp, hippocampus, Pyr, 
pyriform cortex; cc; corpus callosum. 
 
 
 
  50 
Figure 2: At E12.5 Arx cKO cortices display a slight decrease in cortical progenitor 
proliferation and increase in differentiation. Immunohistochemistry for ßIII -tubulin (TUBB3) 
in E12.5 control (A, A’) and Arx cKO cortices (B, B’) highlights an increase in the number of 
differentiated young neurons in Arx cKO cortex compared to control, corresponding to a slight 
decrease in the number of KI67+ proliferative progenitor cells (C-D’). (E-F’) Merge of ßIII -
tubulin and KI67 staining in control and Arx cKO cortex. (F) Quantification of the percentage ßIII 
-tubulin + and KI67+ cells at E12.5 in control and Arx cKO cortex. 
  51 
Figure 3: Proliferation rate of radial glia cells and intermediate progenitors is reduced in 
Arx cKO cerebral cortex. E14.5 coronal sections from control (left) and Arx cKO cortices 
(right) are directly compared. Ki67 stained sections (A, B) and corresponding higher 
magnification (E, F) reveal an overall reduction of proliferating cells in Arx cKO cortex 
compared to wild type; (C) quantifications of Ki67+ cells in a 150 µm bin extending from the 
ventricular to pial surface: control 259±21.8 and cKO 202.5±16.3; n=6 for each, p value < 0.001. 
(D, E, F, G, H, I) PAX6, TBR2, BrdU and PH3 immunolabelings performed on wild type and Arx 
cKO sections from embryos treated with 1 hour pulse of BrdU. (D’-E’’’) Reduction in the 
number and in the signal intensity of PAX6+ cells (D’, E’) and in the number of BrdU+ (D’’, E’’) 
in Arx cKO cortices compared to the control.  (F’-G’’’) A reduction in the number of TBR2+ 
cells (arrowheads, F’, G’) and a decrease in TBR2+/BrdU+ double positive cells (arrowheads, 
D’’’, E’’’) in Arx cKO cortices compared to the control are shown (H’-I’) Reduction of PH3+ 
cells is observed in the Arx cKO cerebral cortex, greater in the basal rather then in the apical 
region. (J) Quantifications of total PAX6+ and TBR2+ cells, dual-labeled PAX6+/BrdU+ and 
TBR2+/BrdU+ double positive cells and PH3+ in E14.5 wild type and Arx cKO cortices are 
shown. 
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Figure 4: Arx cKO cerebral cortex shows no increase in apoptosis with respect to control 
during embryonic development.  Immunohistochemistry for Caspase3 (red) in control and Arx 
cKO cortices at E13.5 (A, B), E15.5 (C, D) and E17.5 (E, F). Comparable numbers of Caspase3+ 
cells can be observed in both control and Arx cKO coronal sections. 
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Figure 5: Cell cycle kinetic is not affected in both Arx cKO VZ and SVZ progenitors, but 
IPC growth fraction is severely reduced (A-J’’) Cortical fields of BrdU and TBR2 labelings 
performed on control and Arx cKO cortices at 5 (0.5, 3.5, 6.5, 9.5 and 12.5 hours) of the 6 time 
points of the BrdU cumulative labeling experiment are shown. (K-M) Double labeling for TBR2 
and KI67 and quantification of KI67+TBR2+ normalized on total TBR2+ cells reveals a severe 
reduction of the IPC proliferating fraction in Arx cKO with respect to control. (N-O) Labeling 
indices (L.I.) for both control and cKO RG and IPC progenitor (calculated as the ratio between 
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TBR2+ BrdU+ cells on the total of TBR2+ and normalized on the IPC growth fraction in the 
latter case), are plotted against correspondent BrdU labeling times and the interpolating lines are 
drawn. (P) Evaluation of cell cycle duration (Tc) and S-phase duration (Ts) are reported. 
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Figure 6: Arx cKO cortices display fewer IP proliferating cells also later on during 
development. Immunohistochemistry for TBR2 (red) and KI67 (green) in control (A) and Arx 
cKO (B) cortices at E17.5 revealing a decrease in TBR2+ cells in the cKO cortex with respect to 
control, with very little percentage of them, still proliferating (TBR2+ Ki67+). (C) Quantification 
of the percentage of proliferating IPC cells (TBR2+ Ki67+) on the total IPC cells (TBR2+) in 
both the control and cKO cortex (ctrl: 15.57±2.50; cKO: 7.69±0.26, n=4 each, p=0.0458, t test) 
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Figure 7: Increased cell cycle exit affects Arx cKO progenitors and the progeny of TBR2+ 
cells is reduced. (A,B) E14.5 control and Arx cKO cortical sections were double labeled for Ki67 
and BrdU, following BrdU injection at E13.5. (C) Quantification of the proportion of cells 
leaving the cycle (leaving fraction: BrdU+Ki67-/tot BrdU+ cells). (D, E) E15.5 coronal sections 
and relative higher magnifications (D’, E’) of control and Arx cKO in the transgenic background 
Tbr2::GFP analyzed for GFP expression reveal a reduction in number and intensity of GFP+ cells 
in Arx cKO SVZ , subplate (SP) and cortical plate (CP) (F). 
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Figure 8: Cell cycle length is normal in Arx cKO SVZ precursors while (A-B’’) E14.5 wild 
type and Arx cKO cortical sections were double labeled for KI67 and BrdU following a 1-hour 
BrdU pulse. (C) Quantifications of KI67+ cells in control and cKO SVZ and of Brdu+ Ki67+ 
double positive cells on the total of Ki67+. 
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Figure 9: ARX is expressed in TBR2+ intermediate precursor cells. (A) E14.5 coronal 
sections of cortex and relative higher magnifications (A’, A’’, A’’’) of control brains labeled for 
TBR2 (A’) and ARX (A’’). (A’’’) Higher magnification showing the presence of ARX and TBR2 
co-stained cells in both cortical VZ and SVZ. 
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Figure 10: Cortical layering is altered in Arx cKO brains. Immunohistochemistry for 
molecular markers identifying deeper cortical layers at E16.5 and both deeper and upper cortical 
layers at P1 and P14, in control and Arx cKO cortices (A-T). (A, B) TBR1+ cells are slightly 
decreased in layer V-VI neurons and increased in subplate in E16.5 Arx cKO cortices with respect 
to the controls; (C, D) CTIP2 immunolabeling shows the same alterations observed with TBR1 
although more prominantly. (E, F) At P1, similar numbers of TBR1+ cells in Arx cKO cortices 
with respect to control are detected as well as a similar number of CTIP2+ cells in both layer V 
and VI (G, H). (I, J) SATB2 is decreased in upper layer neurons (II, III) in the Arx cKO cortices 
with respect to the controls; (K, L) Similarly, staining for CUX1 (layers II-IV) shows a 
diminution of upper cortical layer neurons in Arx cKO cortices with respect to controls. (M-P) At 
P14, there are still similar numbers of TBR1+ and CTIP2+ cells in the Arx cKO cortices when 
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compared to controls but still a decrease in SATB2+ cells in layers II/III (Q, R). Similarly, there 
are also still fewer CUX1+ cells in the Arx cKO cortices (S, T). (U) Quantifications of TBR1+ 
and CTIP2+ cells in layer VI and V and of SATB2+ and CUX1+ at E16.5, P1 and P14 in both 
control and Arx cKO cortices. TBR1+ and CTIP2+ cells at P14. Cells positive for each molecular 
marker were counted 25% of the cortex in P1 and in a 200 µm bin in P14, both from the 
ventricular to the pial surface in both control and Arx cKO cortices. 
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Figure 11: Outline of the gene expression profile analysis and hierarchical clustering of the 
transcripts found differentially expressed between control and Arx KO dorsal 
telencephalon. (A-I) The 86 genes found differentially expressed between control and Arx KO 
cerebral cortices were grouped according to the protein function they codify for, in: (A) 
transcription factors; (B) receptors; (C) intracellular regulatory proteins; (D) structural proteins; 
(E) extracellular matrix proteins; (F) extracellular regulatory proteins;  (G) junctions and adhesion 
molecules; (H) carriers and transporters; (I) Y linked genes. (J) 7 genes found misregulated by 
microarray analysis were selected for quantitative real-time RT-PCRs (qPCRs) validation. 
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Figure 12: The cyclin dependent kinase inhibitor (CKi) Cdkn1c is ectopically expressed in 
Arx KO cortical VZ and SVZ and it is a direct transcriptional target of ARX. In situ 
hybridizations for Cdkn1c on telencephalic coronal sections at different embryonic stages (E12.5-
E14.5) of control (left) and Arx KO (right) brain tissues; in situ hybridizations for Arx on control 
coronal sections at the corresponding developmental stages are also showed. (A-C) At E12.5 
Cdkn1c transcript is detected in the neo-formed SVZ in control brains (arrowheads, A’); 
differently, in Arx KO, it is significantly upregulated in both VZ and SVZ (arrowheads, B’), 
where Arx is normally expressed at this stage (C). Similarly, Cdkn1c is found upregulated in Arx 
KO VZ and SVZ at E14.5 (arrowheads, E’) whereas in the relative control sections it is still 
barely detected in the SVZ (arrowheads, D’). (G) A 5 kb genomic region upstream to the murine 
Cdkn1c gene locus was screened for the presence of paired homeodomain binding sites: a 
palyndromic sequence 5’-ATTAGCATAAT-3’, highly conserved in mouse, rat, human and 
orangutan, was found between -71/-81 bp before the Cdkn1c transcription start site (+1). (H) A ∼ 
500 bp (-549/-68) genomic region containing the putative ARX binding site, a ∼ 750 bp (-1490/-
720) containing some TA rich repeats and the same 500 bp (-549/-68) genomic region with the 
binding site mutagenized 5’-AGGAGCATCCT-3’ were separately cloned in a construct 
containing the Luciferase gene and tested in transcriptional activity assays in P19 cells. When the 
500 bp(-549/-68)-Luc construct is cotransfected with pCAG-ArxIRESGFP a reduction in 
Luciferase expression compared control plasmid pCAG-IRESGFP cotransfection was appreciable 
(0.67±0.04; n=3, p<0.005,); similar reduction was observed when the corepressor TLE1 was 
cotransfected (0.60±0.07, n=3); finally, higher reduction was detected when both ARX and TLE1 
were cotransfected (0.42±0.06, n=3). Differently, ARX cotransfected with the 750 bp(-1490/-
720)-Luc induced only a slight reduction in the basal transcriptional activity (0.94± 0.01, n=3, 
p<0.05,), even in combination with TLE1. When the binding site 5’-ATTAGCATAAT-3’ was 
mutagenized in 5’-AGGAGCATCCT-3’, no significant reduction in Luciferase expression was 
appreciable in cotransfection experiments. (I) Immunoprecipitation of E14.5 telencephalic 
chromatin with anti-ARX, anti-GFP and IgG only. Primers spanning the 500 bp(-549/-68) 
genomic region upstream to the Cdkn1c, and Ebf3, Cdkn1b and Cdkn1a regulative regions were 
used for PCR analysis of the immunoprecipitated DNA. Enrichment of the PCR products in anti-
ARX immunoprecipitated chromatin sample compared to the anti-GFP and IgG only samples was 
evaluated 
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Figure 13: Expression of the cyclin dependent kinase inhibitor (CKi) Cdkn1c in Arx KO 
cortical VZ and SVZ, at later stages of development. In situ hybridizations for Cdkn1c on 
telencephalic coronal sections at late embryonic stages (E16.5-E18.5) of control (left) and Arx 
KO (right) brain tissues; in situ hybridizations for Arx on control coronal sections at the 
corresponding developmental stages are also showed. At E16.5, in control sections, Cdkn1c 
transcript is still detected in the SVZ (arrowheads, A’) and it starts to accumulate also in the 
cortical plate cells (arrows, A’); in the corresponding Arx KO tissues, upregulation in the VZ 
(arrows, B, B’) is still evident as well as the expression in the cortical plate (arrowheads, B, B’). 
Consistently, Arx transcript is still detected at E16.5 in control section VZ (C). At E18.5, only a 
slight up-regulation of Cdkn1c is still detectable in Arx KO VZ (E, E’) in agreement with a 
reduced residual expression of Arx at this stage (F). 
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Figure 14: Schematization of the molecular mechanism through which ARX controls 
cortical progenitor expansion. ARX expression in the cortical VZ/SVZ normally represses 
CDKN1C expression allowing progenitor cell proliferation and expansion. Loss of Arx in the 
VZ/SVZ causes precocious CDKN1C upregulation in the cortical progenitors cells, which results 
in a mild decrease in proliferation of RGCs and a significant loss of IPC proliferation, with 
consequent cell cycle exit. This ultimately results in a loss of upper layer neurons in the adult 
cortex. 
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CHAPTER 3: Conditional loss of Arx from the developing dorsal telencephalon 
results in behavioral phenotypes resembling mild human ARX mutations 
 
Introduction 
 Aristaless-Related Homeobox gene (ARX) is one of the more commonly mutated 
genes causing X-linked intellectual disability (XLID) (Lin CH et al. 2009; Shoubridge C 
et al. 2010). Over 44 distinct mutations have been found resulting in a spectrum of 
phenotypes (Shoubridge C et al. 2010).  Mutations that lead to a deletion or truncation 
along with those that reside in the homeodomain cause primarily brain malformation 
phenotypes such as X-linked lissencephaly associated with ambiguous genitalia (XLAG), 
hydranencephaly, and Proud syndrome (agenesis of the corpus callosum) (Bonneau D et 
al. 1992).  Point mutations outside the homeodomain, in non-conserved amino acids of 
the homeodomain, missense mutations, and poly-alanine track expansion mutations lead 
to various neurological phenotypes that are mainly characterized by intellectual 
disability, but frequently also include epilepsy (typically infantile spasms), autism, or 
dystonia but typically have no structural brain defects (Lafaucheur L et al. 1992; Turner 
G et al. 2002).  The only phenotype consistently observed in patients with all ARX 
mutations is intellectual disability.  
 Mice with a germline loss of Arx have a thin disorganized cortex, malformed 
thalamus, major white matter tract defects (corpus callosum and thalamo-cortical), and 
mislocalization and loss of interneurons in the cortex and striatum (Kitamura K et al. 
2002).  Unfortunately these mice die shortly after birth precluding behavioral or EEG 
phenotyping.  In the developing telencephalon Arx is expressed in pallial progenitor cells 
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located in the ventricular zone (VZ) and in subpallial sub-ventricular zone (SVZ) cells, 
which generate interneurons that populate the cortex, striatum, and hippocampus.  The 
selective removal of Arx from interneurons results in no brain malformations, but similar 
to the knockout mouse they have fewer interneurons in the cerebral cortex and 
hippocampus (Marsh E et al. 2009).  They also have a severe epilepsy phenotype with 
features overlapping those observed in some patients with ARX mutations (Marsh E et al. 
2009).  Hence, it appears that perturbation of the developing interneurons is sufficient to 
produce an epileptic phenotype that recapitulates the seizures found in patients with ARX 
mutations.  Selective removal of Arx from the pallial progenitor cells using an shRNA 
against Arx at e13.5 causes the progenitors cells to prematurely exit the cell cycle and the 
VZ, however because this was just a partial knock down it is unclear what affect this has 
on later development of the cortex (Friocourt G et al. 2008). 
 In contrast to mice with a germline loss of Arx (Kitamura K et al. 2002), mice 
deficient for Arx in cortical interneurons (Arx-/Y Dlx5/6Cre mice) have a normal cortical 
thickness, indicating an interneuron independent function of Arx on cortical thickness 
(Marsh E et al. 2009).  To examine the role of Arx in cortical development, we mated 
ArxF/X mice to Emx1Cre mice, which selectively deletes Arx from the dorsal telencephalon 
(pallium).  These mice have a thin cerebral cortex, similar to the Arx knockout, and are 
predominantly missing superficial layer neurons, sparing deeper layer neurons, due to a 
loss of proliferating intermediate progenitor cells (Colasante G et al. 2013).  Since loss of 
Arx in interneurons appears to cause the epilepsy phenotype we sought to determine 
which characteristics of the human ARX patient phenotype might be explained by loss of 
Arx in cortical progenitor cells.  Thus, we performed a detailed behavioral and anatomic 
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analysis of the Arx-/Y Emx1Cre mice to determine the functional consequences of Arx loss 
in cortical progenitors and whether this loss may model specific phenotypic aspects of 
human ARX patients.  
 
Materials and Methods: 
Mice 
Arx conditional mutant mice (ArxF/X) (Fulp CT et al. 2008) were maintained on a 
C57Bl/6 background.  To inactivate Arx in the dorsal telencephalon specifically during 
development ArxF/X heterozygous female mice were crossed with homozygous male 
Emx1Cre/Cre animals also on a C57Bl/6 background (Jax Mouse Strain 005628).  
Genotyping to distinguish wild type, floxed, and cre positive alleles was performed as 
described (Jin XL et al. 2000; Fulp CT et al. 2008).  Mice were maintained at the 
Children’s Hospital of Philadelphia animal facility on a 12:12 hours light-dark cycle 
(lights on 0600-1800 hours) and ad libitum Lab Diet mouse food 5LG4.  All experiments 
were approved by the Institutional Animal Care and Use Committee of the Children’s 
Hospital of Philadelphia. 
EEG Recordings and Analysis 
All electrophysiologic studies were conducted as previously described (Marsh E 
et al. 2009). Adult animals at least 3 months old were used for all EEG recordings. 
Briefly, under isoflorane anesthesia, 4 electrodes were stereotaxically implanted (3 
cortical-left and right frontal, right parietal and a hippocampal depth) using the 
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coordinates in our previous publication (Marsh E et al. 2009).  The animals recovered in 
their home cage for 48 hours prior to recordings and then were transferred to the 
recording cage and recorded with a Triangle Biosystems preamplifer and a Stellate EEG 
recording system (Natus Technologies) for 48 to 96 hours.   
The EEG and video were reviewed manually for the presence of seizures.  
Background EEG was quantified as previously published (Marsh E et al. 2009).  Briefly 
ten 10-second segments of awake and asleep EEG were randomly selected, but checked 
for artifact and behavioral state.  The awake state was defined as the period when the 
mouse was moving with hippocampal theta present.  In contrast, when the animal was 
still, head down, and delta dominated the EEG it was considered asleep.  A Fast Fourier 
Transform (FFT) was calculated for each segment (MATLAB 2010b, Mathworks, Inc., 
Natick, MA) and the resultant spectrums were quantified by calculating the power in 
selected bandwidths  (Delta 0.1-3.5Hz, Theta 3.5-8.5Hz, Alpha 8.5-13Hz, Beta 13-25Hz, 
and Gamma 25-100Hz) and dividing by total FFT power.  The percent power in each bin 
was averaged across genotype and compared using a Student’s t-test in Excel (version 
12.2.7, Mircosoft).  To correct for the 10 comparisons, a difference was considered 
significant if the p value was less than 0.005 (the Bonferoni correction).  Eight mutant 
mice and six wild type mice were recorded for 3 days each, but only 4 wild type and 4 
mutant mice were analyzed using the FFT. 
Behavioral Studies 
Behavioral testing was conducted during the light phase between 1000 and 1800 
hours (h), starting at 8 weeks of age and each individual paradigm was separated by at 
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least 2 days.  Mice were handled for 5 minutes each day for 3 days prior to the beginning 
of testing.  Six cohorts of mice were used for behavior testing.  Each cohort consisted of 
at least two different litters of mice.  See Chapter 3; Table 1 for a list of the tasks each 
cohort of mice performed.  The numbers of mice tested for each task are listed below.  
Only male mice were tested and all cohorts were a mix of mutant mice (ArxF/Y 
Emx1Cre/Cre) and wild type littermates (ArxX/Y Emx1Cre/Cre).  Cleaning wipes (PDI Sani-
Cloth Plus germicidal disposable cloth) were used to clean equipment between mice.  
With the exception of grip strength and rota-rod, all paradigms were video recorded and 
automatically scored using ANY-maze software (Stoelting Co., Wood Dale, IL). 
Grip Strength 
The grip strength of the mice was tested using a grip strength meter (080312-3 
Columbus Instruments, Columbus, Ohio).  Each mouse was tested in 6 consecutive trials; 
the first 3 were for forelimbs, and then 3 more for hindlimbs.  The value from each trial 
was recorded and the forelimb and hindlimb trials were each averaged and taken as the 
result for that mouse. (Golub MS and SL Germann 2001; Fowler SC et al. 2002; Munn E 
et al. 2011)  The results for all mutant mice and their wild type littermates were compared 
using a two-tailed unpaired Student’s t-test in Excel; WT=13 and Mut=14.  
Rota-rod 
Mice were tested on a rota-rod from Ugo Basile (Model 47600, Comerio, Italy).  
The mice were tested in groups, 5 at a time for 6 minute trials with 5 trials per day for 4 
days.  The rota-rod was used in acceleration mode, accelerating every 6 seconds up to 60 
rpm. The latency until falling for each mouse was recorded.  Between trials the mice 
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were placed back into their home cages. (Crawley JN 2007; Miwa JM and A Walz 2012; 
Heyser CJ et al. 2013)  Each day, the trials were averaged and the genotypes were 
compared across the four days using a repeated measure ANOVA in Prism (version 5.0, 
GraphPad, San Diego, CA); WT=13 and Mut=14. 
Home Cage Activity 
Mice were placed in plastic EEG recording boxes (Marsh E et al. 2009) with their 
normal bedding and food and were allowed to acclimate for 2 days before being video 
recorded for 3 days. The video was analyzed using an in-house program written in 
MATLAB that detects movement by subtracting pixels between each video. The pixel 
counts were averaged over the 3 days of recordings for each genotype. The genotypes 
were compared using a Student’s t-test in Excel; WT=8 and Mut=8.  
Open Field 
A 53 x 53 cm plastic box with 22cm high walls and no top was used in a well-lit 
room (450 lumens/meter2).  The mice were placed in the center of the box and allowed to 
roam freely in the box for 15 minutes.  The mice were video recorded and scored using 
ANY-maze software.  ANY-maze scored a mouse to be in the periphery if it was within 
13cm of the wall of the box.  Otherwise they were considered to be in the center of the 
box. (Crawley JN 2007; Buschert J et al. 2013; Han Q et al. 2013)  The ratio of time in 
the center to time in the periphery was calculated and averaged.  The distance traveled 
during the test and the number of crossings between the center of the box and the 
periphery were also calculated and averaged using the ANY-maze software.  Genotypes 
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were compared using a two-tailed unpaired Student’s t-test in Microsoft Excel version 
12.2.7; WT=20 and Mut=21.  
Light/Dark Box 
A 55 x 28cm plastic box with 22cm tall walls and divided in half was used.  Both 
sides of the box were accessible by a 7.5 x 7.5cm door in the middle.  One half of the box 
was clear with no top and the other half was black plastic with a covered top.  The mice 
were placed in the box on the light side and allowed to roam freely for 15 minutes.  The 
tests were video recorded and scored using ANY-maze software. (Bale TL et al. 2000; 
Bourin M and M Hascoet 2003; Crawley JN 2007)  The ratio of time in the light side of 
the box to time in the dark side was calculated and averaged for each genotype and 
compared using a two-tailed unpaired Student’s t-test in Excel.  The linear distance the 
animal traveled during the test and the number of crossings between the two sides was 
also calculated and analyzed the same way; WT=17 and Mut=14. 
Marble Burying  
A clear plastic cage, 32 x 43cm, with 19cm high walls was filled with 5cm deep 
corncob bedding evenly covering the bottom.  Twenty-four marbles, spaced 6cm apart, 
were placed evenly on top of the bedding.  The mice were placed in the box and allowed 
to roam freely and bury marbles for 30 minutes.  After 30 minutes, the number of marbles 
buried at least two thirds of the marble’s depth with bedding was recorded. (Deacon RM 
2006; Krass M et al. 2010; Chioca LR et al. 2013)  The tests were video recorded and 
scored for distance traveled using ANY-maze software.  The number of marbles buried, 
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and the distance traveled was calculated and averaged for each genotype and compared 
using a two-tailed unpaired Student’s t-test in Excel; WT=8 and Mut=8.  
Morris Water Maze 
The Morris water maze consists of a 128cm diameter round plastic tub filled with 
21°C water to within 15cm of the top of the tub and a 0.5 cm above a square clear plastic 
platform.  White tempera paint was mixed into the water until it was opaque enough that 
the edge of the platform could not be seen from the side. Spatial cues were placed around 
the tub and were not moved for the duration of the experiments.  The mice were tested 
using 4 trials per day for 5 days.  The mice were placed in the tank in a different location 
for each trial and the order of locations was changed each day (see (Vorhees CV and MT 
Williams 2006) and Chapter 3;Table 1).  In each trial mice were allowed to swim for up 
to 60 seconds before being led to the platform.  Once on the platform, the mice were 
allowed 10 seconds of observation time.  The latency to find the platform (up to 60 
seconds) for each trial was recorded and averaged for each day.  The genotypes were 
compared using a repeated measures ANOVA in Prism.  On the 6th day a probe trial was 
performed to test the memory of the location of the platform.  In this trial, the platform 
was removed and the mice swam around the tub, searching for the missing platform for 
60 seconds.  The time spent in the quadrant of the tub where the platform had been and in 
the opposite quadrant was recorded and compared using an unpaired Students t-test.  A 
reversal test was then performed for 5 days following the probe trial.  During this test, the 
platform was placed on the opposite side of the tub and the mice were re-trained, with the 
same protocol of 4 trials a day for 5 days.  A reversal probe trial was performed on the 6th 
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day in the same fashion as the first probe trial. (Crawley JN 2007; Harris L et al. 2013)  
The same statistical analysis was performed for the reversal trials as for the learning test; 
WT=20 and Mut=21. 
Contextual Fear Conditioning 
Each mouse was placed in a modular test chamber (Model ENV-307W, Med 
Associates, Inc., Georgia, VT) and allowed to explore the box for 2 ½ minutes before a 2 
second foot shock of 1.12 mA was given with a SA shock scrambler (ENV-4145), a 
digital timer (SG-592), and a 1 Amp power supply (SG-501 Med Asoociates, Inc., 
Georgia, VT).  The mouse was then left in the box for another 28 seconds before being 
removed to its home cage.  Twenty-four hours later the mouse was placed in the same 
modular test chamber and was video recorded for 5 minutes using ANY-Maze software, 
which quantified time spent not moving (freezing). (Wood MA et al. 2005; Crawley JN 
2007; Cole JT et al. 2010)  The amount of time spent freezing was compared across 
genotypes using an unpaired Student’s t-test; WT=17 and Mut=14. 
Social Choice Test 
A social choice apparatus was constructed from the description by Sankoorikal 
(Sankoorikal GM et al. 2006).  The bottom of the chamber was covered with bedding and 
that bedding was changed for each mouse tested.  The protocol used to test the mice was 
the same as the one used in Fairless et al. 2008.  Briefly, the mice were first acclimated to 
the chamber for 10 minutes.  Then a novel object was added to one tube and a 
gonadectomized male mouse to the other tube and the behavior of the test mouse was 
recorded for 5 minutes.  The tubes were then removed and the behavior of the test mouse 
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while interacting with the gonadectomized mouse was observed for another 5 minutes, 
unless the mouse was aggressive in which case both mice were removed immediately.  
The test mouse was then returned to its home cage.  A single novel object was used for 
all tests and was cleaned, along with the apparatus before each test.  Each 
gonadectomized male was used only once per day.  The side of the chamber that had the 
mouse or the object was alternated between tests. (Nadler JJ et al. 2004; Crawley JN 
2007) The tests were video recorded and scored using ANY-maze software.  The time 
spent in the social section, the center, and the non-social section was compared using a 
Two-way ANOVA in Prism.  The ratio of the amount of time spent within 3cm of the 
tube with the mouse (sniffing social tube) verses the time spent within 3cm of the tube 
with the object (sniffing object tube) was calculated and averaged for each genotype and 
compared using a Student’s t-test in Excel.  The number of entries to either the social 
section of the box (mouse) or the non-social section of the box (object) was also 
calculated and compared across genotypes; WT=15 and Mut=18.  
Buried Food Test of Olfaction 
For 2 days prior to the test each mouse was given a Froot Loop (Kellogg's® Froot 
Loops® Cereal) in its cage and the next day the cage was checked to make sure they ate 
the Froot Loop.  Mice were then deprived of food for 24 hours.  The next day a Froot 
Loop was buried in 1.5 cm deep bedding in a clean normal mouse cage with nothing else 
but the top of the cage.  A mouse was placed in the cage and the time to dig up the piece 
of food documented, up to 10 minutes. (Moy SS et al. 2004; Crawley JN 2007; Yang M 
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and JN Crawley 2009)  The average time for each genotype was compared using an 
unpaired Student’s t-test; WT=8 and Mut=8.  
In Situ Hybridization 
P21 and P30 mice were perfused transcardially with phosphate buffered saline 
(PBS) followed by 4% paraformaldehyde (PFA).  The brains were removed and post 
fixed in 4% PFA overnight at 4°C.  Fixed brains were cryoprotected in 30% sucrose and 
coronally sectioned at 10um.  All slides were baked at 65°C for 20 minutes, post-fixed in 
4% PFA for 10 min, washed in phosphate buffered saline with 0.1% Tween-20 (PBT).  
The slides were then acetylated for 10 min in 0.1 M TEA (1.86% triethanolamine, 0.4% 
10N NaOH, 0.5% acetic anhydride, and water) and washed in PBT.  The Glutamate 
decarboxylase 67 (GAD67) probe (courtesy of Dr. N. Tillakaratne (Erlander MG et al. 
1991)) was added at 1:1000 in pre-warmed hybe solution (50% formamide, 5x SSC, 2% 
blocking reagent (Roche, Mannheim, Germany; 11096176001), 0.1% Triton, 0.15 
CHAPS, 1mg/ml tRNA from yeast, 5mM EDTA, 50ug/ml heparin) and incubated 
overnight at 65°C.  Slides were washed with 5x SSC, then incubated with 1xSSC/ 50% 
formamide 30 minutes at 65°C, then TNE (10mM Tris pH 7.5, 500nM NaCl, 1mM 
EDTA, and water) for 10 minutes at 37°C, then RNaseA for 30 min at 37°C and washed 
with TNE and then at 65°C with 2x SSC and 0.2x SSC for 20 min, each.  Then the slides 
were incubated in MABT pH 7.5 (100mM maleic acid, 150mM NaCl, 0.1%tween-20, 
and water) and blocked in MABT with 2% blocking reagent (Roche) and 20% goat serum 
for 1 hour at room temperature.  Slides were incubated overnight at 4°C in MABT with 
2% blocking reagent and 5% goat serum and anti-DIG antibody 1:2500 (Roche, 
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11093274910).  The slides were then washed with MABT and then NTM.  The slides 
were then incubated with 1ml BM Purple (Roche, 11442074001) in the dark, overnight at 
room temperature.  The slides were then washed with NTM and PBS, fixed in PFA, 
dehydrated to 100% ethanol, and mounted with Permount (SP15-500, Fisher Scientific). 
Immunohistochemistry 
P21 mice were processed as described in in-situ section above.  The brains were 
cryoprotected in 30% sucrose and cryosectioned coronally at 10um or 16um.  All slides 
were baked at 37°C for 30 minutes.  Two antibodies, Somatostatin (SST; Rabbit 3387-1, 
Epitomics, Burlingame, CA; 1:50) and Parvalbumin (Parv; Mouse MAB1572, Millipore, 
Billerica, CA; 1:100) were used to assess for changes in interneuron subtypes.  For the 
Sst antibody, antigen retrieval was performed in citric acid-based Antigen Unmasking 
Solution (H-3300, Vector Laboratories, Burlingame, CA) autoclaved at 105°C for 20 
minutes.  For the Parv antibody the MOM blocking reagent (FMK-2201, Vector 
Laboratories) was used for 30 minutes followed by blocking for 30 minutes with 10% 
normal goat serum (Sigma) in TBST (TBS with 0.5% triton) all at room temperature.  
After antigen retrieval, SST sections were blocked for 30 minutes at room temperature 
with 0.5% normal goat serum (Sigma) in TBST.  Anti Parv primary was diluted in 1% 
normal goat serum in TBST and Anti-Sst was diluted in 0.5% normal goat serum in 
TBST and incubated on slides overnight at 4°C.  The secondary antibodies used were a 
biotinylated goat anti-mouse (BA-9200, Vector Laboratories, 1:300) and biotinylated 
goat anti-rabbit (BA-1000, Vector Laboratories, 1:300), diluted in TBST and placed on 
slides for 30 minutes at room temperature.  The biotinylated secondary antibodies were 
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subsequently incubated with ABC kit mix (PK-6100, Vector Laboratories) in PBS for 30 
minutes and then ImmPACT DAB for 2 minutes (SK-4105, Vector Laboratories).  Slides 
were counterstained with hematoxylin, dehydrated, and mounted with Permount.  Stained 
sections were viewed on a Leica DM6000B equipped with a Leica DFC360FX digital 
camera.  10X images were taken of the entire cortex for each section and then stitched 
together using Fiji version ImageJ 1.45b. 
Nissl Staining 
Cresyl Violet acetate (C5042, Sigma-Aldrich) (0.1g) was mixed with 100 mL 
distilled water.  To each 10ml of Cresyl Violet acetate solution 50µL of 15% glacial 
acetic acid was added and the solution was filtered to make Nissl stain.  Cryosections 
were covered in Nissl stain for 10 minutes and then washed 2 times with distilled water.  
The sections were destained by dipping them once in acid alcohol (50% ethanol/50% 
distilled water with 0.1% HCl).  Slides were mounted with Flouromount-G (0100-01, 
SouthernBiotech) and imaged the same as the immunohistochemistry sections.  
Cell Counting 
For the GAD67 counts a 1mm area of the cortex from the pial surface to the white 
matter directly above the hippocampus (2mm posterior to Bregma) and 2mm from the 
medial edge of the cortex was counted.  For the basolateral amygdala counts all of the 
Nissl stained neurons in the basolateral amygdala (2.1mm posterior to Bregma) were 
counted.  Cell counts were averaged for each genotype and compared using an unpaired 
Student’s t-test.  
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MRI 
Adult mice brains were processed as described above, and then post-fixed in 4% 
PFA for 2 weeks.  Prior to MRI the samples were transferred to a PBS 1X solution 
containing 0.2mM Gd-DTPA (Gadopentetic acid)(J140 Omniscan GE Healthcare).  At 
the time of scanning the samples were removed from the PBS/Gd-DTPA solution, rinsed 
with pure PBS and introduced in a short 11 mm glass tube containing Fomblin (317993 
Sigma-Aldrich) to provide a susceptibility match and a black background for the images.  
Bubbles were carefully removed by tapping gently on the tube.  An inverted Pasteur 
pipette was inserted on top of the brain to maintain the tissue immersed in the Fomblin.  
MRI was performed at 9.4T in a vertical bore magnet (Avance III Bruker-Biospin Inc) 
using the micro 2.5 self-shielded gradients (2.5G/cm/A) and a 15 mm RF coil.  The 
image acquisition and reconstruction was performed with the Paravision software 5.1 
(Bruker Biospin Inc.).  The temperature of the sample was maintained at 37C.  Diffusion 
tensor images and T2 weighted 3D images of the brain tissue were obtained sequentially 
with the DTIEpi 30 directions and the 3D turboRARE Bruker protocols respectively.  
The following conditions were used: for the DTI, field of view (FOV) 20 x 12.8 x 10 
mm, data size (SI) 128x80x64, which results in a resolution of 160 m3, number of 
averages (NEX) 2, repetition time (TR) 1250 ms, echo spacing (Te) 26 ms, 8 segments, 
bandwidth 300kHz, diffusion gradients 3ms, diffusion gradient separation 7.53ms, 30 
directions, 5 A0 images and a B value of 1500 s.mm2.  The duration of the acquisition 
was 12h 26 min. For the 3D rare the parameters were FOV 19.2 x 12.8 x 9.6 mm, SI 
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256x176x128, giving a resolution of 75 m3, 5 NEX, TR 1500 ms, Te 13 ms, echo train 8 
which results in an average echo time of 39 ms and a 5h long experiment.  To analyze the 
T2 weight images for volume data on specific brain regions.  We used a registration-
based segmentation method to extract various structures in T2-weight MR images 
of mouse brains.  A mouse brain atlas with accompanying labels of structures of interest 
was registered to the target image.  We adapted the mouse atlas from Johns Hopkins 
University, which is available to the public (http://cmrm.med.jhmi.edu/).  Registration 
was aligned followed by non-rigid diffeomorphic warping using Advanced 
Normalization Tools (ANTs), which is an open-source software freely available online.  
The labels were also transformed to the target space by the same warping and thus 
completed the segmentation. 
 
Results: 
Arx-/Y Emx1Cre mutant mice have normal numbers of interneurons  
 We previously found that Arx-/Y Emx1Cre mice have reduced numbers of upper 
cortical layer neurons with relative sparing of neurons in the deeper layers (Colasante G 
et al. 2013).  Arx expression was preserved in the developing ventral telencephalon and in 
the interneurons migrating from the ganglionic eminence to the cortex (Colasante G et al. 
2013).  Several studies have found that changes in the development of cortical excitatory 
neurons can affect interneuron migration into the cortex (Sessa A et al. 2010; Lodato S et 
al. 2011).  Therefore, to confirm that cortical interneurons were not adversely affected by 
the loss of upper layer neurons we first assessed the total number of interneurons using a 
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GAD67 in situ hybridization probe on sections from brains of P21 Arx-/Y Emx1Cre 
(mutant) mice and their wild type littermates (ArxX/Y Emx1Cre).  Similar numbers of 
interneurons were found in the mutant brains when compared to wild type brains 
(Chapter 3;Fig. 1B,C; WT= 137.3±5.84 and Mut=124±2.65; n=3 for each; p=0.1359).    
 We next sought to exclude the possibility that while the total number of 
interneurons was unchanged, subtypes of interneurons were disproportionately 
represented (Azim E et al. 2009). Labeling for two interneuron subtypes, parvalbumin 
and somatostatin, which together mark 50-70% of all cortical interneurons (Xu X et al. 
2010; Rudy B et al. 2011), revealed both types to be similarly represented (parvalbumin 
WT=50±5 and Mut=53±2; n=3 for each; p=0.6575; somatostatin WT=37±7.23 and 
Mut=29±2.89; n=3 for each; p=0.3897)(Chapter 3;Fig. 1C).  Thus, both the total number 
and representative subtypes of interneurons were unaltered by the loss of Arx from the 
dorsal telencephalon. 
Arx-/Y Emx1Cre mice do not have seizures 
 Patients and mice with ARX/Arx mutations have seizures as a principle feature.  
The conditional loss of Arx from developing interneurons in the ventral telencephalon 
(Arx-/Y Dlx5/6Cre) results in a severe seizure phenotype (Marsh E et al. 2009).  
Furthermore, mice with a polyalanine track expansion mutation or with a point mutation 
in the homeobox also have seizures (Kitamura K et al. 2009; Price MG et al. 2009).  To 
determine if the loss of Arx from the cortical projection neuron progenitor pools (Arx-/Y 
Emx1Cre mice) is also associated with seizures, video-EEGs were recorded for up to 96 
hours following our previously published protocol (Marsh E et al. 2009).  Review of up 
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to 96 hours of EEG and video recordings from 8 mutant mice and 6 control animals 
revealed no seizures in the either the mutant or control mice.  However, there were 
differences that were observed in the EEG (Chapter 3;Fig. 1A).  Qualitatively, the EEG 
appeared to be slower in the Arx-/Y Emx1Cre mice than the wild type mice (Chapter 3;Fig. 
1A).  To confirm our visual interpretation, we performed a Fast Fourier Transforms 
(FFTs) on randomly selected awake and sleep EEG segments in the cortex from 6 control 
and 4 mutant mice.  An increase in Delta (Awake: WT=23.50±4.34 and Mut=29.69±4.85 
p=0.0036, Sleep: WT=22.19±3.84 and Mut=31.77±3.84 p=2.3x10-8) and decrease in 
Alpha or Beta (Awake; Alpha: WT=9.28±0.77 and Mut=11.06±1.53 p=0.0017; Sleep; 
Beta: WT=16.88±1.00 and Mut=14.20±1.24 p=9.2x10-7) and Gamma (Awake: 
WT=32.08±3.92 and Mut=24.83±2.89 p=9.1x10-6; Sleep: WT=30.96±3.11 and 
Mut=24.16±2.46 p=4.7x10-6; WT n=6 and Mut n=4) power was present during both sleep 
and awake states (Chapter 3;Fig. 1B). Similar, results were seen in the FFTs for the 
hippocampal recordings (Chapter 3;Fig2A,B).  Interestingly, this change in EEG 
frequency content is the opposite from the Arx-/Y Dlx5/6Cre mice, which had an increase in 
faster (Beta and Gamma) activity (Marsh E et al. 2009). 
Arx-/Y Emx1Cre mutant mice have normal spatial learning and memory 
An invariant feature among males with an ARX mutation is a severe intellectual 
disability (Shoubridge C et al. 2010).  To investigate whether the Arx-/Y Emx1Cre mice had 
intellectual disabilities we performed several learning and memory tests.  Prior to 
performing these tasks, physical strength and coordination defects were evaluated and 
excluded.  Grip strength and rota-rod testing revealed no differences between the Arx-/Y 
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Emx1Cre mice and their wild type littermates (Chapter 3;Fig. 3A,B Grip strength: 
Forelimb: WT= 0.042±0.0033, n=13 and Mut=0.052±0.0053, n=12; p=0.1030; Hindlimb: 
WT= 0.079±0.0055, n=13 and Mut=0.082±0.0044, n=12; p=0.3447; Rota-rod: WT n=13 
and Mut n=12; p=0.0801).  Thus, no motor deficits were uncovered suggesting the 
mutant mice should have normal physical capabilities.  
Once a motor abnormality was excluded, the Morris water maze test was 
performed to assess spatial learning and memory. The mice were first trained with spatial 
cues around the tank and the platform hidden.  There was no difference in learning the 
task as both mutant mice and wild type littermates located the platform in similar times 
each day of training (Chapter 3;Fig. 4A; WT n=20 and Mut n=21; p=0.0669).  Next, 
memory for the platform location was probed by recording the time spent in the original 
quadrant of the platform after the platform was removed (Chapter 3;Fig. 4B).  Again, 
there was no difference found between the mutant and wild type mice (Chapter 3;Fig. 4B: 
Time (secs) in platform quadrant: WT=22.8±1.47 and Mut=25.6±1.97; p=0.271; Time in 
opposite quadrant: WT=9.61±1.07, n=20 and Mut=7.7±1.28, n=21; p=0.256).  Finally, 
reversal learning and memory testing, which is a more sensitive indicator to changes in 
cortical function, was tested by relocating the platform to the opposite side of the tank.  
No differences were noted in this measure of cortically-mediated learning (Chapter 3;Fig. 
4C; WT n=20 and Mut n=21; p=0.1545) or memory (Chapter 3;Fig. 4D: Time (secs) in 
platform quadrant: WT=19.5±0.87 and Mut=19.9±1.33; p=0.762; Time in opposite 
quadrant: WT= 11.7±0.85, n=20 and Mut=11.7±1.02, n=21; p=0.997).  Thus, by the 
highly-standardized and accepted Morris water maze paradigm the Arx-/Y Emx1Cre mice 
exhibit normal spatial learning, memory, and reversal learning. 
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Arx-/Y Emx1Cre mutant mice have normal fear memory, but are hyperactive 
 In some mutant mouse strains hippocampal based spatial learning and memory 
can be normal despite alterations in other forms of learning such as fear conditioning 
learning because the hippocampus is not as involved in this type of learning (Angelo M et 
al. 2003; d'Isa R et al. 2011; Albarran-Zeckler RG et al. 2012).  To test whether the Arx-/Y 
Emx1Cre mutant mice had a learning and memory deficit independent of spatial learning, 
we tested the animals in a conditioned fear-learning task.  The mutant mice spent 
significantly less time freezing than their wild type littermates did both during the 
training session and during the testing session (Chapter 3;Fig. 4E: percentage of time 
spent freezing training: WT=10.5±1.06, n=17 and Mut=5.57±0.82, n=14; p=0.00099; 
percentage of time spent freezing testing: WT=52.1±3.65, n=17 and Mut=34.4±4.99, 
n=14; p=0.0086).  This suggests that the mutant mice are hyperactive; a finding 
confirmed by the longer distances travelled by the mutant mice than their wild type 
littermates during the testing session  (Chapter 3;Figure 5A: distance traveled: 
WT=2.43±0.42, n=17 and Mut=4.00±0.49, n=14; p=0.0217).  The ratio of the percentage 
of time spent freezing during the training session verses the testing session indicated that 
the mutant mice learn the contextual fear conditioning just as well as their wild type 
littermates (Chapter 3;Figure 5B: ratio of percentage of time spent freezing traing/testing: 
WT=5.36±0.43, n=17 and Mut=6.80±1.31, n=14; p=0.3097). 
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Arx-/Y Emx1Cre mutant mice are anxiolytic, more exploratory, and more active than 
wild type mice.  
Surprisingly, no learning deficit was uncovered but there was a suggestion of a 
more active state, therefore we further examined the mutants exploratory and anxiety 
behaviors.  To evaluate the anxiety level of the Arx-/Y Emx1Cre mutant mice open field and 
light/dark box tests were used.  For the open field test, mice with a higher ratio of the 
time spent in the center to time spent in the periphery of the chamber are considered to 
have a low anxiety-like or anxiolytic phenotype.  Mutant mice appeared anxiolytic as 
they spent significantly more time in the center of the box compared to their wild type 
littermates (Chapter 3;Fig 6A: WT= 0.170±0.019, n=20 and Mut=0.229±0.020, n=21; 
p=0.0405).  For the light/dark box, testing the ratio of time spent on the light side of the 
box compared to the time on the dark side of the box was used as a measure of anxiety.  
Again, the mutant mice spent significantly more time on the light side when compared to 
their wild type littermates suggesting a reduced anxiety-like phenotype (Chapter 3;Fig 
6C: WT= 0.891±0.118, n=17 and Mut=1.61±0.202, n=14; p=0.00204).  
Both the open field and light/dark box tests can also be used to quantify the 
activity level of mutant mice.  In both, the mutant mice travelled further than their wild 
type littermates indicating a higher activity level in the mutant mice (Chapter 3;Fig. 
6B,D: Open field: WT= 65.9±3.02 cm, n=20 and Mut=77.6±3.79 cm, n=21; p=0.0201; 
Light/dark box: WT= 12.2±0.867 cm, n=17 and Mut=20.2±1.13 cm, n=14; p=0.000007).  
Similarly, the mutant mice crossed between the light and dark side of the box and 
between the center and the periphery of the open field, which also indicates higher 
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activity (Chapter 3;Fig. 7A,B: Open field: WT=117±6, n=20 and Mut=158±8, n=21; 
p=0.0000863; Light/dark box: WT= 28±1, n=17 and Mut=40±4, n=14; p=0.00143).  
However, the mutant mice displayed normal activity levels in home cage recordings so 
they appear to be more active only in novel environments (Chapter 3;Fig 3C: 
WT=13.75±1.73 Δ pixels/frame, n=8 and Mut=12.59±1.84, n=8; p=0.5191). 
Since our data suggests that the Arx-/Y Emx1Cre mice are both anxiolytic and more 
active in both the open field and the light/dark box tests, we wanted to determine whether 
the increased activity was confounding our anxiety test results.  Therefore, we performed 
a marble burying test, another anxiety test, but one in which less activity constitutes 
lower anxiety (Thomas A et al. 2009). We found that the mutant mice buried significantly 
fewer marbles then the wild type animals (Chapter 3;Fig. 6E: WT= 6.13±1.25, n=8 and 
Mut=0±0, n=8; p=0.00759) yet they were still hyperactive based on distance traveled in 
the novel cage (Chapter 3;Fig. 6F: WT= 85.34±2.10cm, n=8 and Mut=93.42±5.94cm, 
n=8; p=0.2322), similar to the open field and light dark box.  This indicates that although 
still hyperactive in a novel environment, they were less anxious than their wild type 
littermates.  Together, the data suggests that the anxiety and hyperactivity phenotypes are 
separable and the Arx-/Y Emx1Cre mice are both less anxious and hyperactive when 
compared to their wild type littermates.  
Arx-/Y Emx1Cre mutant mice have social deficits 
 One of the core symptoms of autism is abnormal social interactions (Crawley JN 
2007; Silverman JL et al. 2010).  To test for the mice for “social” deficits we performed 
the social choice task (Crawley JN 2007; Silverman JL et al. 2010).  In the social choice 
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task the test mouse is given a choice between a novel object and novel mouse.  As mice 
are normally social animals they should typically spend more time exploring a novel 
mouse then a novel object.  Therefore, we compared the time spent in the area of the 
novel mouse (social), the time spent in the center, and the time in the section with the 
novel object (nonsocial) (Sankoorikal GM et al. 2006; Fairless AH et al. 2008).  The Arx-
/Y Emx1Cre mutant mice appear to have a socialization deficit as they spent significantly 
less time in the social section of the box (Chapter 3;Fig. 8A; Time spent in social section: 
WT= 142.07±8.54, n=15 and Mut=111.37±4.28, n=18; p<0.001).  In addition, the mutant 
mice entered the social section of the box significantly fewer times as compared to the 
wild type mice (Chapter 3;Fig. 8B; WT= 2.97±0.50, n=15 and Mut=1.44±0.14, n=18; 
p=0.00952).  Similarly mutant mice spent significantly less time sniffing around the 
novel mouse verse the novel object than their wild type littermates did (Chapter 3;Fig. 
8B; WT= 4.53±0.80, n=15 and Mut=2.15±0.18, n=18; p=0.01379).   
The olfactory ability of the mice was tested using the buried food test in order to 
rule out the possibility that reduced olfactory ability was confounding the social choice 
test. Both the mutant mice and their wild type littermates found the buried Froot Loop in 
similar amounts of time showing that the mutants have normal olfactory skills (Chapter 
3;Fig 8C; WT=143.38±34.86 and Mut=242.13±79.60, n=8 for each; p=0.2834).  
Arx-/Y Emx1Cre mutant mice have smaller cerebral cortices, amygdalas, and white 
matter tracts 
In addition to the neurocognitive and behavioral deficits patients with various 
ARX mutations exhibit, structural defects such as lissencephaly, agenesis of the corpus 
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callosum and microcephaly are present in many patients (Suri M 2005; Friocourt G et al. 
2006; Gecz J et al. 2006).  In an effort to begin linking the structural defects with the 
neurocognitive deficits we examined regional size variation and connectivity. Using 
structural MRI in fixed Arx-/Y Emx1Cre and wild type mouse brains the volume of various 
brain structures was calculated (Chapter 3;Fig. 9).  As observed in Nissl stained sections 
the cerebral cortical volume was significantly smaller in the mutant mouse (Colasante G 
et al. 2013)(Chapter 3;Fig. 9A,C,E).  The MRIs also revealed the corpus callosum and 
anterior commissure to be significantly reduced in volume, as is also found in patients 
with various ARX mutations (Proud VK et al. 1992; Bonneau D et al. 2002; Marsh E et al. 
2009)(Chapter 3;Fig. 9A,C,D,E).  However, analysis of the MRIs also reveled that the 
amygdala volume was significantly smaller in the mutant mice (Chapter 3;Fig. 9E).  It is 
possible that there are changes to the amygdala in the Arx-/Y Emx1Cre mice since both Arx 
and Emx1 are expressed in the amygdala (Puelles L et al. 2000; Medina L et al. 2004; 
Poirier K et al. 2004; Remedios R et al. 2007).  To confirm this finding, we counted 
neurons in the basolateral amygdala in Nissl stained sections and found that the number 
of neurons was reduced (Chapter 3;Fig. 10C; WT=1118±124 and Mut=891±152, n=3 for 
each; p=0.01952).  Interestingly, the behavioral phenotypes of decreased anxiety and loss 
of fear memory have been hypothesized to represent amygdala dysfunction (Phillips RG 
and JE LeDoux 1992; Grillon C et al. 1996; Tottenham N et al. 2010; Schienle A et al. 
2011). Combining the MRI volume changes with the loss of cells in the basolateral 
amygdala suggest that amygdala dysfunction could explain at least part of the Arx-/Y 
Emx1Cre behavioral phenotype.  Over all, the MRI data are consistent with the hypothesis 
that the Arx-/Y Emx1Cre mutant mice have a long-range connectivity defect.  Unexpectedly 
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the thalamus was also significantly smaller in the mutant mice even though the Cre is not 
expressed in the diencephalon, suggesting a possible corticothalamic connectivity defect 
(Chapter 3;Fig. 9E) that could contribute to the abnormal behaviors found in these mice.   
 
Discussion: 
 Loss of Arx in dorsal progenitors resulted in structural, functional and behavioral 
deficits in the Arx-/Y Emx1Cre mice.  Specifically, we demonstrated that disruption of both 
local superficial cortical connections, long-range connections between hemispheres and 
within limbic regions results in a hyperactive and anxiolytic mouse that socializes poorly.  
Of note, these behaviors all occur in the absence of ongoing epilepsy as a confounding 
variable.  By comparing the deficits in the Arx-/Y Emx1Cre mice to those of the previous 
Arx mutant mice and the clinical phenotype of ARX patients we can begin to shed some 
insight into the possible function of different cortical regions, connections, and the lack 
of a role for seizures in generating the behaviors found in the Arx/ARX mice and patients.     
 The complete Arx knockout mouse created by the Kitamura lab had a thin cortex 
due to decreased cortical progenitor proliferation during development (Kitamura K et al. 
2002).  Loss of Arx expression in the cortical VZ at e13.5 causes cortical progenitor cells 
to exit the cell cycle and the VZ prematurely (Friocourt G et al. 2008).  Our lab recently 
determined that Arx-/Y Emx1Cre mice have thinner and smaller cortices and are specifically 
missing superficial layer neurons and not deeper layer neurons (Colasante G et al. 2013).  
A loss of proliferative intermediate progenitor cells was found to be the cause of the 
thinner cortex (Colasante G et al. 2013).  Unlike most other Arx mutant mice, these mice 
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do not die at a young age, likely because they do not develop seizures (Chapter 3;Fig. 
1A) and have intact olfaction allowing for normal feeding behaviors.  Consistent with a 
lack of seizures, Arx-/Y Emx1Cre mice have normal numbers of interneurons in their 
cortices (Chapter 3;Fig. 1B).  Therefore, we wanted to examine the behavioral phenotype 
of these mice to determine the impact on cognitive functioning of isolated loss of upper 
layer neurons, without the complicating factors of interneuron loss and seizures as found 
in all other Arx mutant mice models.  
Intellectual disability is the common feature of all human ARX mutations.  To 
determine what aspects of the human condition the Arx-/Y Emx1Cre mice recapitulate, we 
tested learning and memory.  Somewhat surprisingly, the Morris water maze test did not 
reveal any abnormalities in spatial learning and memory and the contextual fear 
conditioning test did not reveal any abnormalities in fear learning and memory (Chapter 
3;Fig. 4A-E).  This contrasts to the Arx(GCG)7/Y mice and the ArxPL/Y mice which showed 
impaired spatial learning in the win-shift task of the eight-arm radial maze and impaired 
passive avoidance learning (Kitamura K et al. 2009).  The Arx(GCG)7/Y mice also showed 
impaired procedural learning in the win-stay task (Kitamura K et al. 2009). Another 
Arx(GCG)10+7 mouse also showed impaired learning of the fear conditioning task (Price 
MG et al. 2009). These data indicate that the learning deficits seen in the other Arx 
mutant mice might be due to, either individually or in combination, the of loss of 
interneurons in the cortex and the hippocampus or the seizure activity they exhibit. 
The Arx-/Y Emx1Cre mice registered less anxiety-like behavior and increased 
exploration as evidenced by their spending significantly more time in the center of the 
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open field and in the light part of the light/dark box than their wild type littermates 
(Chapter 3;Fig. 6A and B). In addition, the mice were hyperactive, having travelled a 
further distance during both tests (Chapter 3;Fig. 6B and D).  These findings are similar 
to the Arx(GCG)10+7 mice that also were reported to have a low anxiety and hyperactivity 
phenotype (Price MG et al. 2009).  However, other Arx mutant mice (Arx(GCG)7/Y and 
ArxPL/Y mice) were more anxious in the same tests (Kitamura K et al. 2009).  Based upon 
these varying results, no conclusions can be made regarding the relationship of these 
behavioral phenotypes to alterations in excitatory or inhibitory interneurons of the cortex 
or seizure burden.  These changes in anxiety in Arx mutant mice could also be explained 
by changes in the amygdala, which was not investigated in any of the other Arx mutant 
mice, but do exist in the Arx-/Y Emx1Cre mutant mouse. 
Autistic features, including social deficits and stereotypies, have been described in 
patients with ARX mutations (Turner G et al. 2002; Shoubridge C et al. 2010).  The Arx-/Y 
Emx1Cre mice appear to have social deficits in the social choice test (Chapter 3;Fig. 8A).  
This is similar to the Arx(GCG)10+7 mice for which there was a reported deficit in the tube 
test for social dominance (Price MG et al. 2009).  This suggests that the autistic 
phenotypes of these mice could be due either to changes in the excitatory neurons of the 
cortex, amygdala or the connections between the two.  
 Arx-/Y Emx1Cre mice have decreased cerebral cortical and amygdala volumes, 
which can be correlated with the behavioral phenotypes of decreased anxiety-like 
behavior, hyperactivity, and social deficits.  The cortical defect described in these mice 
(Colasante G et al. 2013) is one explanation for these behavioral findings.  Another 
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possible rationale for these behavioral deficits is defects in the amygdala structure as 
indicated by the volume and neuron number changes.  The combined or separate roles of 
these two brain structures in mediating these behavioral functions requires further 
investigation.  The white matter tract abnormalities (including the corpus callosum, the 
anterior commissure, and possibly the cortico-thalamic tract) suggest a loss of long-range 
connectivity between different brain regions in these mutant mice.  Agenesis of the 
corpus callosum was reported in the Arx knockout mice, but not in the Arx(GCG)10+7, 
Arx(GCG)7/Y, ArxPL/Y, or ArxPR/Y mice (Kitamura K et al. 2002; Kitamura K et al. 2009; 
Price MG et al. 2009).   It has also been documented in some ARX patients with XLAG or 
Proud syndrome and heterozygous females from families with these syndromes (Proud 
VK et al. 1992; Bonneau D et al. 2002; Marsh E et al. 2009).  In contrast, corpus 
callosum agenesis has been seen in both severely affected males and in unaffected carrier 
females making it unlikely for corpus callosal defects alone to be the primary mechanism 
of the behavioral deficits seen in mice and patients.  
 The differences in the frequency composition of the EEG between the Arx-/Y 
Emx1Cre and wild type mice were reminiscent of the slow background and increase in 
Delta activity that is present in most children with a diffuse encephalopathy, including 
children with ARX mutations.  Though nonspecific, a slow EEG background suggests 
diffuse brain dysfunction as might be expected in a cortical layer defect (Pedley TA 
1980).  Interestingly, the composition of the EEG in the Arx-/Y Emx1Cre and Arx-/Y 
Dlx5/6Cre are different, with the interneuron specific mouse (Arx-/Y Dlx5/6Cre) gaining 
faster frequency activity and the excitatory neuron specific mouse (Arx-/Y Emx1Cre) 
gaining slower activity (Marsh E et al. 2009).  This difference supports the notion that 
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interneurons and subcortical structures are necessary for the generation of Theta and 
Gamma oscillations, and local cortical networks are not (Bragin A et al. 1995; 
Whittington MA et al. 2011).     
 The absence of seizures in the Arx-/Y Emx1Cre mice provided a unique opportunity 
to separate out the basic structural and cellular deficits from the resulting seizures on a 
variety of behavioral phenotypes.  Neurologists question the ultimate role of seizures in 
generating the cognitive deficits in their patients (Shinnar S and WA Hauser 2002; 
Hamiwka LD and EC Wirrell 2009; Hermann BP et al. 2009).  These studies demonstrate 
that for ARX related disorders, alterations in anxiety, hyperactivity, social deficits, and 
repetitive behaviors could be unrelated to the epilepsy.  Indeed, the absence of epilepsy, 
altered anxiety, hyperactivity, and social deficits observed in these Arx mutant mice are 
reminiscent of patients with mild ARX phenotypes.  Other phenotypes, like the small 
amygdala, have not been studied in this relatively small patient population.  It remains 
possible that a more thorough brain imaging and behavioral analysis of these patients 
might reveal even more similarities between the Arx-/Y Emx1Cre mice and patients with 
ARX mutations.  
 Overall, the Arx-/Y Emx1Cre mouse line, with the other conditional and mutant Arx 
mice that have been generated offer an opportunity to dissect apart a complex circuit to 
look for local circuit or regional connections that are necessary or sufficient for the 
generation of complex behaviors.  We acknowledge at the onset that this is a difficult 
endeavor as any one change in a developing system alters the others and that both 
cognitive and social behaviors are complex tasks that involve the function of networks, 
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not just cortical regions and layers.  With those caveats in mind, our findings suggest an 
important role for superficial cortical regions and the amygdala, in the generation of a 
hyperactive, anxiolytic, anti-social phenotype.     
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Table 1: Cohorts of mice used in behavior experiments and order of behavior tests.  
Cohort Number of Mice Order of Behavior Tests 
1 WT=3 Mut=4 Grip Strength, Rota-rod, Open Field, Water Maze 
2 WT=10 Mut=8 Grip Strength, Rota-rod, Open Field, Water Maze 
3 WT=13 Mut=9 Light/Dark Box, Open Field, Water Maze, Fear Conditioning 
4 WT=4 Mut=5 Light/Dark Box, Buried Food, Social Choice, Fear Conditioning 
5 WT=11 Mut=13 Buried Food, Social Choice 
6 WT=8 Mut=8 Buried Food 
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Figure 1: Arx-/Y Emx1-Cre mice do not have seizures and have normal interneuron numbers.  
A) Samples of cortex recordings for Arx-/Y Emx1-Cre mice (Mut) and their control wild type 
littermates (ArxX/Y Emx1-Cre), which showed no seizure activity.  B) Quantifications of EEGs of 
the cortex by Fast Fourier Transform (FFT) on both Awake and Sleep segments for wild type and 
mutant mice (Awake; Delta: WT=23.50±4.34 and Mut=29.69±4.85 p=0.0036, Theta: 
WT=19.61±2.60 and Mut=18.32±1.63 p=0.1894, Alpha: WT=9.28±0.77 and Mut=11.06±1.53 
p=0.0017, Beta: WT=15.54±1.46 and Mut=16.11±1.68 p=0.4199, Gamma: WT=32.08±3.92 and 
Mut=24.83±2.89 p=9.1x10-6; Sleep; Delta: WT=22.19±3.84 and Mut=31.77±3.84 p=2.3x10-8, 
Theta: WT=19.32±1.42 and Mut=19.55±1.41 p=0.7178, Alpha: WT=10.65±0.83 and 
Mut=10.32±1.13 p=0.4597, Beta: WT=16.88±1.00 and Mut=14.20±1.24 p=9.2x10-7, Gamma: 
WT=30.96±3.11 and Mut=24.16±2.46 p=4.7x10-7; WT n=6 and Mut n=4).  C) Quantifications of 
interneurons in a 1mm bin of cortex from ventricular to pial surface from in situ hybridizations of 
GAD67 and immunofluorescence staining of parvalbumin and somatostatin on adult brain 
sections showing no difference in total number of interneurons (GAD67; WT= 137.3±5.84 and 
Mut=24±2.65; n=3 for each; p=0.1359) and no change in the number of interneurons of two 
subtypes (Parv; WT=50±5 and Mut=53±2; n=3 for each; p=0.6575; and SST; WT=37±7.23 and 
Mut=29±2.89; n=3 for each; p=0.3897).  Error bars correspond to S.E.  D) GAD67 in situ 
hybridizations on cryosections of P21 brains of wild type (ArxX/Y Emx1-Cre) and mutant (ArxF/Y 
Emx1-Cre) brains.  Section of the cortex just above the hippocampus from pial surface (top) to 
white matter (bottom). Error bars are S.E. 
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Figure 2: Arx-/Y Emx1Cre mice have increased lower frequencies in their EEGs and decreased 
higher frequencies.  A and B) Quantifications of EEGs of the hippocampus by Fast Fourier 
Transform (FFT) on both Awake (A) and Sleep (B) segments for wild type and mutant mice 
(Awake; Delta: WT=20.45±3.55 and Mut=31.18±4.08 p=1.4x10-8, Theta: WT=18.53±1.47 and 
Mut=20.00±2.84 p=0.1531, Alpha: WT=9.08±0.84 and Mut=10.86±1.73 p=0.0049, Beta: 
WT=15.74±1.04 and Mut=15.37±1.77 p=0.5723, Gamma: WT=36.21±2.93 and Mut=22.58±3.39 
p=2.9x10-15; Sleep; Delta: WT=19.85±2.83 and Mut=34.15±2.61 p=3.5x10-20, Theta: 
WT=20.34±1.56 and Mut=18.24±1.91 p=0.0087, Alpha: WT=11.12±0.92 and Mut=9.49±0.92 
p=0.00017, Beta: WT=16.97±0.88 and Mut=13.33±1.13 p=7.1x10-12, Gamma: WT=31.73±3.37 
and Mut=24.78±4.00 p=0.000070; WT n=6 and Mut n=4). Error bars are S.E. 
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Figure 3: Arx-/Y Emx1Cre mice have normal motor strength and coordination.  A) The grip 
strength test was used as measure of motor strength in the wildtype and mutant mice.  Grip 
strength for both fore and hind limbs was similar for the mutant and wildtype mice (Forelimb: 
WT= 0.042±0.0033, n=13 and Mut=0.052±0.0053, n=12; p=0.1030; Hindlimb: WT= 
0.079±0.0055, n=13 and Mut=0.082±0.0044, n=12; p=0.3447).  B) The rotarod test was used as 
measure of motor coordination.  The mutant mice performed just as well in the rotarod test and 
learned to stay on the rotarod just as quickly as their wildtype littermates (WT n=13 and Mut 
n=12; p=0.0801).  C) Home cage activity was similar for mutant mice and their wild type 
littermates (WT=13.75±1.73, n=8 and Mut=12.59±1.84, n=8; p=0.5191). Error bars are S.E. 
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Figure 4: Arx-/Y Emx1-Cre mice have normal spatial learning and memory but impaired 
fear-based memory.  A) Mutant mice and wild type littermates were trained in the Morris water 
maze for 5 days and the mutants learned how to reach the platform just as quickly as their wild 
type littermates (WT n=20 and Mut n=21; p=0.0669).  B) On day 6 with the platform removed 
the mutant mice spent just as much time as their wild type littermates in the correct quadrant 
showing that they remembered where the platform was located (time in platform quadrant in 
seconds: WT=22.8±1.47 and Mut=25.6±1.97; p=0.271; time in opposite quadrant in seconds: 
WT=9.61±1.07, n=20 and Mut=7.7±1.28, n=21; p=0.256).  C) The reversal learning of the mice 
was then tested by retraining them for another 5 days with the platform on the opposite quadrant 
of the tank.  The mutant mice relearned the task just as well as their wild type littermates (WT 
n=20 and Mut n=21; p=0.1545).  D) On day 12 the platform was again removed and the time the 
mice spent in each quadrant was recorded.  The mutant mice spent just as much time in the new 
platform quadrant as their wild type littermates (time in platform quadrant in seconds: 
WT=19.5±0.87 and Mut=19.9±1.33; p=0.762; time in opposite quadrant in seconds: WT= 
11.7±0.85, n=20 and Mut=11.7±1.02, n=21; p=0.997).  E) Contextual fear conditioning was used 
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to evaluate fear learning in wild type and mutant mice. During a 3 min training period the mice 
were given a foot shock and the amount of time spent freezing was recorded.  Twenty-four hours 
later the mice were re-exposed to the context where they were given the foot shock and the 
amount of time they spent freezing over a 5 min period was recorded.  Mutant mice spent 
significantly less time freezing as compared to their wild type littermates both in the training 
period and during testing so therefore they did learn this task  (percentage of time spent freezing 
training: WT=10.5±1.06, n=17 and Mut=5.57±0.82, n=14; p=0.00099; percentage of time spent 
freezing testing: WT=52.1±3.65, n=17 and Mut=34.4±4.99, n=14; p=0.0086). Error bars are S.E. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  100 
 
Figure 5: Arx-/Y Emx1Cre mice are more active than their wild type littermates, but they do 
learn the contextual fear conditioning task. A) The mutant mice traveled a larger distance 
during the testing session of the fear conditioning task than their wild type littermates did 
(WT=2.43±0.42, n=17 and Mut=4.00±0.49, n=14; p=0.0217) indicating they are more active 
during the test. B) Therefore even though the mutant mice froze significantly less than their wild 
type littermates they did so during both parts of the task so the ratio of freezing during training to 
freezing during testing is not different between the two genotypes (WT=5.36±0.43, n=17 and 
Mut=6.80±1.31, n=14; p=0.3097). Error bars are S.E. 
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Figure 6: Arx-/Y Emx1-Cre mice are less anxious and more active than wild type mice. A) In 
the Open Field test the ratio of time spent in the center to time spent in the outside area of the box 
was used as a measure of anxiety.  The mutant mice spent more time in the center of the box than 
their wild type littermates indicating they are less anxious (WT= 0.170±0.019, n=20 and 
Mut=0.229±0.020, n=21; p=0.0405).  B) The linear distance traveled by the mice during their 
fifteen minute testing period was calculated as a measure of their activity level.  The mutant mice 
traveled further than their wild type littermates during the open field test indicating that they are 
hyperactive (WT= 65.9±3.02, n=20 and Mut=77.6±3.79, n=21; p=0.0201). C) For the Light/Dark 
Box assay the ratio of time spent in the light side of the box to time spent in the dark side of the 
box was used as a measure of anxiety.  The mutant mice spent more time in the light side of the 
box than their wild type littermates indicating that they are less anxious (WT= 0.891±0.118, n=20 
and Mut=1.61±0.202, n=21; p=0.00204).  D) The linear distance traveled by the mice during their 
ten minute testing period was calculated as a measure of their activity level.  The mutant mice 
traveled further than their wild type littermates during the light/dark box test again indicating that 
they are hyperactive (WT= 12.2±0.867, n=20 and Mut=20.2±1.13, n=21; p=0.000007). E) The 
number of marbles buried in the Marble Burying assay was used as a measure of anxiety with 
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increased burying meaning increased anxiety (WT= 6.13±1.25, n=8 and Mut=0±0, n=8; 
p=0.00759).  F) The amount of distance traveled by the mice during the thirty minute testing 
period was used as a measure of activity level (WT= 85.34±2.10, n=8 and Mut=93.42±5.94, n=8; 
p=0.2322). Error bars are S.E. 
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Figure 7: Arx-/Y Emx1Cre mice are more active and have more crossings in the open field and 
light/dark box tests.  A) The mutant mice crossed from the center to the periphery in the open 
field test more often than the wild type mice did (WT=117±6, n=20 and Mut=158±8, n=21; 
p=0.0000863) indicating they are more active during the test. B) Similarly, the mutant mice 
crossed from the light side to the dark side of the box in the light/dark box test more than the wild 
type mice did (WT= 28±1, n=17 and Mut=40±4, n=14; p=0.00143). Error bars are S.E. 
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Figure 8: Arx-/Y Emx1-Cre mice have social deficits.  A) The social abilities of mutant and wild 
type mice were assessed using the social choice test, the time spent in the novel mouse section 
(social), the center of the box, and the novel object section (nonsocial) was compared using a 
Two-way ANOVA.  The mutant mice spent significantly less time in the social section of the box 
than their wild type littermates did (Time spent in social section: WT= 142.07±8.54, n=15 and 
Mut=111.37±4.28, n=18; p<0.001).  B) The mutant mice spent significantly less time sniffing the 
novel mouse tube than their wild type littermates did as compared to the object tube (Sniffing: 
WT= 4.53±0.80, n=15 and Mut=2.15±0.18, n=18; p=0.01379).  The mutant mice also entered the 
social section of the box few times as compared to the non-social section than their wild type 
littermates did (Entries: WT= 2.97±0.50, n=15 and Mut=1.44±0.14, n=18; p=0.00952).  C) To 
assess the olfactory ability of the mice the buried food test was used.  If the mice have normal 
olfactory abilities they should be able to find the Froot Loop buried in the bedding.  Both the 
mutant mice and their wild type littermates were equally capable of finding the Froot Loop. 
(WT=143.38±34.86 and Mut=242.13±79.60, n=8 for each; p=0.2834). Error bars are S.E. 
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Figure 9: Arx-/Y Emx1-Cre mice have hypoplastic corpus callosums and anterior 
commissures.  MRIs were made of three brains from mutant mice and three brains from their 
wild type littermates.  A) A midsagittal section from an MRI of a wild type brain.  The white 
arrows mark the rostral and caudal ends of a normal corpus callosum.  C) A midsagittal section 
from an MRI of a mutant brain.  The white arrows again mark the ends of the corpus callosum 
showing that the corpus callosum is both shorter and thinner in the mutant mice.  B) A rostral 
coronal section from an MRI of a wild type brain.  The white arrow marks the middle of the 
anterior commissure.  D) A rostral coronal section from an MRI of a mutant brain.  The white 
arrow marks the middle of the anterior commissure showing that in the mutant it is much thinner. 
E) Table of volumes (mm3) of brain regions of wild type and mutant mice from T2W MRI data 
and comparisons between the wild type and mutant volumes for each region.  
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Figure 10: Arx-/Y Emx1-Cre mice have a loss of neurons in the basolateral amygdala.  A and 
B) Coronal brain sections of adult mutant mice and their wild type littermates were stained with 
Nissl, which labels all neurons.  A’ and B’) Enlarged sections showing the basolateral amygdala 
region (dotted white outline) which was counted.  C) Quantification of number of neurons 
counted in the basolateral amygdala of the Arx-/Y Emx1-Cre mice and their wild type littermates 
showing that the mutant mice have fewer neurons in the basolateral amygdala as compared to 
wild type littermates (WT=1118±124 and Mut=891±152, n=3 for each; p=0.01952). Error bars 
are S.E. 
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CHAPTER 4: Discussion 
 
The work presented herein, expands the data on the role of Arx into its function in 
dorsal progenitors.  Mutations in ARX produce a spectrum of intellectual disability and 
epilepsy phenotypes in human patients (Shoubridge C et al. 2010).  Arx is expressed in 
progenitor cells that produced both the excitatory and inhibitory neurons of the cerebral 
cortex during development (Colombo E et al. 2004).  However, Arx studies have focused 
primarily on its role in interneurons during cortex development, as this was predicted to 
be the cause of the severe epilepsy found in patients with ARX mutations.  The original 
report of Arx dysfunction in the mouse, however, found deficits in the proliferation and 
thickness of the cerebral cortex as well as in interneuron migration (Kitamura K et al. 
2002).  The decreased proliferation in the pallial (the dorsal part of the developing 
telencephalon) progenitor zone along with the expression of Arx in this region clearly 
pointed to a role for Arx in cortical progenitor cell development (Kitamura K et al. 2002; 
Colombo E et al. 2004).   
To address the function of Arx in pallial progenitor cells, in utero electroporation 
was performed with an shRNA construct, to decrease Arx expression, and an 
overexpression construct, to observe changes with increased Arx function (Friocourt G et 
al. 2008).  Knockdown of Arx in the cortical progenitors was found to cause premature 
cell cycle exit while Arx overexpression in the same population resulted in a lengthening 
of the cell cycle (Friocourt G et al. 2008).  However, the methodology used in these 
experiments limits a full interpretation of the role of Arx in cortical progenitor cells, but 
confirmed that Arx has a role in normal cortical progenitor cell proliferation and 
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differentiation.  Thus, we sought to more thoroughly investigate the role of Arx in the 
regulation of proliferation and differentiation of pallial progenitor cells during cortex 
development.  Employing conditional genetic methodologies we eliminated Arx from the 
cortical proliferative zones by crossing the Emx1Cre driver mouse with the floxed Arx 
mouse (Fulp CT et al. 2008).  The result of this cross was to effectively abrogate Arx 
specifically from the dorsal telencephalon cortical progenitor cells starting at embryonic 
day 9.5 (E9.5).  This removed Arx from those cells that will give rise to all cortical 
excitatory neurons and glia, at the time of their birth and persisting through development. 
Arx controls cortical progenitor cell number through repression of Cdkn1c 
The Arx-/Y Emx1Cre mice were found to have smaller, thinner and somewhat 
disorganized cortices along with agenesis of the corpus callosum, mimicking the 
morphological abnormalities seen in Arx-/Y mice.  The Arx-/Y mouse recapitulated some of 
the structural abnormalities found in X-linked lissencephaly with ambiguous genitalia 
patients (XLAG) with severe ARX mutations.  This indicates that these abnormalities are 
due to a loss of Arx in cortical progenitor cells rather than other cell types in the cortex.   
These Arx-/Y Emx1Cre mice have fewer radial glia progenitor cells (RGCs) and 
intermediate progenitor cells (IPCs) in their cortices during development (Chapter 2: Fig. 
3).  With decreased proliferation of the IPCs and increased cell cycle exit of the RGCs, 
but normal cell cycle length for both types of progenitors (Chapter 2: Figs. 3, 5, and 7). 
To uncover the transcriptional pathways mediating this loss of proliferation and 
premature cell cycle exit we compared transcript profiles between Arx KO cortices and 
wild type cortices.  Eighty-three genes were found to be differentially expressed in the 
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Arx KO cortices as compared to controls (Chapter 2: Fig. 11).  One of these genes was 
Cdkn1c, which was overexpressed in Arx KO cortices when compared to controls and at 
e14.5 is overexpressed specifically in the VZ (ventricular zone) and SVZ (subventricular 
zone).  Cdkn1c is a cell cycle dependent kinase inhibitor that regulates cell cycle 
progression.  Expression of the protein results in cell cycle exit (Sherr CJ and JM Roberts 
1999).  Cdkn1c was determined to be a direct transcriptional target of Arx and therefore 
the effector protein by which Arx regulates proliferation and cell cycle exit in cortical 
progenitor cells.  In agreement with this conclusion overexpression of Cdnk1c in the 
cortex causes progenitor cells to exit the cell cycle and differentiate (Tury A et al. 2011).  
Furthermore, mice with a loss of Cdnk1c have an increase of proliferation of RGCs and 
IPCs with a greater effect on IPCs (Mairet-Coello G et al. 2012).  Together this data 
provides the most direct evidence for Arx regulating cell cycle exit through repression of 
Cdnk1c in cortical progenitor cells.   
The microarray expression profiles of Arx knockouts from different cortical and 
subcortical regions provides clear evidence that Arx regulates different genes in different 
cell types during different stages of development (Fulp CT et al. 2008; Colasante G et al. 
2009)(Chapter 2: Fig. 11).  For example Cdkn1c did not appear as a target on either of the 
two microarrays of the ventral telencephalon, but it does in the dorsal telencephalon (Fulp 
CT et al. 2008; Colasante G et al. 2009)(Chapter 2: Fig. 11).  In fact, comparing the two 
microarrays done by the same group but in different regions revealed only 5 target genes 
found in both the dorsal and ventral telencephalon (Colasante G et al. 2009)(Chapter 2: 
Fig. 11).  This is not completely surprising given that Arx is expressed at different 
developmental stages of the cell types formed from the ventral telencephalon verses the 
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dorsal telencephalon.  In the dorsal telecephalon, Arx is expressed in actively dividing 
progenitor cells correlating with a regulatory role in the cell cycle.  In the ventral 
telencephalon Arx is expressed in the interneurons as they are born, during migration, and 
into maturation, so it makes sense that in addition to another cohort of transcription 
factors it would also regulate signaling receptors and cytoskeletal regulatory proteins.  
From this data, our lab hypothesized that Arx is regulating different groups of genes in 
different cell types explaining how varying mutations and/or a loss of the protein can 
have differential effects in diverse brain regions.  Supporting this hypothesis is work from 
the Golden lab that found Arx with a polyalanine expansion mutation was sufficient for 
normal excitatory neuron development but not interneuron development (Nasrallah MP et 
al. 2012).  The differential effect was apparently due to the Arx polyalanine tract 
expansion mutation loosing the ability to repress a subset of its target genes, but not 
others.  This finding was reported to be due to a failure of Arx to bind to one of its 
cofactors (Tle1) (Nasrallah MP et al. 2012).  Another member of the Golden lab also 
found that Arx has different binding preferences for different DNA sequences when it is 
bound to different proteins, indicating it may bind with different cofactors in different 
cell types (Cho G et al. 2012). 
To further understand the network of genes regulated by Arx, Quille and 
colleagues performed chromatin immunoprecipitation assays on promoter arrays from 
both whole brain tissue and a neuroblastoma (N2a) cell line and compared the resulting 
targets (Quille ML et al. 2011).  Interestingly, this experiment did not pull down Cdkn1c, 
but did pull down Cdkn1a, another cyclin dependent kinase inhibitor in the same family 
of proteins with similar functions (Quille ML et al. 2011).  Because the whole brain was 
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used in this assay its impossible to know in what cell type Arx binds to Cdkn1a.  It 
remains possible that Arx binds to the promoter of Cdkn1a in the cortical progenitor cells 
and regulates their cell cycle exit through expression of that gene or Arx could be 
regulating Cdkn1a in a different cell type.  Given our RT-PCR analysis in the dorsal 
telencephalon showing there was no increase in the expression of Cdkn1a in the Arx 
knockout as compared to controls, it seems most likely Arx is regulating Cdkn1a in a 
different cell type (Chapter 2: Fig. 11).  
Loss of Arx in the progenitor cells changes the structure of the cortex 
The radial glia (RGCs) and intermediate progenitor cells (IPCs) give rise to all of 
the excitatory neurons that will form the adult cortex.  Therefore, by regulating cell cycle 
exit in these two cortical progenitor populations Arx regulates both the number and types 
of excitatory neurons produced in the cortex during development.  There is currently 
some debate in the field regarding whether IPCs can produce all of the excitatory neuron 
subtypes in the cortex or whether they can only produce superficial layer neurons (for 
review see (Kriegstein A et al. 2006; Pontious A et al. 2008)).  Our finding of a loss of 
superficial neurons in the adult cortex in the Arx-/Y Emx1Cre mice with a relative 
preservation of deeper neurons is consistent with the hypothesis that intermediate 
progenitor cells (IPCs) produce only upper layer neurons (Kriegstein A et al. 2006; 
Pontious A et al. 2008)(Chapter 2: Fig. 10).   
In turn this loss of upper layer neurons in the cortex seems to result in a loss of 
connectivity in the brain as evidenced by the decrease in major white matter tracts, the 
corpus callosum and the anterior commissure, that connect distant cortical regions 
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(Chapter 2: Fig.1; Chapter 3: Fig. 9).  In order to prove that the change is these white 
matter tracts was a direct result of the loss of these upper layer neurons in the cortex more 
experiments will need to be performed.  For example a retrograde or anterograde label 
(DiI or Neurobiotin) injected into the upper cortical layers in the Arx-/Y Emx1Cre mice and 
wild type littermate controls could map projections of layer 2/3 axons to see if fewer are 
found in the corpus callosum or the anterior commissure in the mutant mice.  I performed 
a series of these proposed experiments, but was unable to specifically label only layer 2/3 
neurons, likely due to a technical issues with the injection methods employed.  
Alternative methods include: a replication deficient lentivirus expressing GFP injected 
into superficial cells in an adult brain and targets traced; permanently labeling layer 2-3 
neurons by crossing the Arx-/Y Emx1Cre line with a Satb2 or Cux1 reporter mouse; or 
using in utero electroporation of a Tau-GFP construct at e15.5 to label the projections of 
the superficial layer neurons specifically.  This embryonic method of labeling could be 
useful for looking at these cells at different points of development to determine if perhaps 
these cells do project early in development but are unable to maintain those projections.   
Defects in the corpus callosum, either agenesis or hypoplasia, can be the result of 
a primary failure of axons to cross the midline, or due to a primary loss or depletion in 
the number of neurons producing the axons destined to cross the midline.  Based on my 
data I hypothesize that the corpus callosum is thinner due to decreased generation of 
callosal projecting neurons in the superficial layers of the cortex.  Therefore, no change 
would be found in the remaining neuronal projections over the course of development 
because the cells that are formed most likely project and are maintained normally.  This is 
how a transcription factor that is expressed only at one time point early in the 
  113 
development of these cortical cells can have a profound effect on the ultimate structure 
and function of the cortex. 
Arx-/Y Emx1Cre mice have slow background EEG 
Our studies also provide some insight into the role of Arx in excitatory neurons 
and how this influences electrical activity in the brain.  Since Arx was only lost in the 
excitatory neurons of the neocortex in Arx-/Y Emx1Cre mice it was not surprising that the 
total number of interneurons and relative number of the two main subtypes of 
interneurons was preserved in these mutants (Chapter 3: Fig. 1).  Most interestingly, 
unlike all other Arx mutant mouse models, the Arx-/Y Emx1Cre mice do not appear to have 
seizures, further supporting the interneuron origin underlying epileptogenesis in these 
mice.  Even without seizures, the Arx-/Y Emx1Cre mice have an abnormal EEG pattern 
with an increase in slower frequencies and a decrease of faster frequencies (Chapter 3: 
Fig. 1).  This slow EGG pattern is indicative of brain dysfunction and is seen in many 
developmental disorders, particularly epileptic encephalopthies, such as Lennox-Gastaut 
syndrome, Dravet’s syndrome, and West syndrome (Kandel ER et al. 2000; Zupanc ML 
2009).  West syndrome is caused by various mutations in ARX including polyalanine tract 
expansions and duplications, missense mutations, and deletions (Turner G et al. 2002; 
Hirose S and A Mitsudome 2003; Kato M et al. 2003; Kato M et al. 2004; Wohlrab G et 
al. 2005; Demos MK et al. 2009; Cossee M et al. 2011).  In addition, this increase in 
slower frequencies and decrease of faster frequencies is also consistent with the EEGs of 
children and adults with Attention Deficit Hyperactivity Disorder (ADHD) (Barry RJ et 
al. 2010; van Dongen-Boomsma M et al. 2010; Loo SK and S Makeig 2012; Woltering S 
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et al. 2012; Clarke AR et al. 2013) and our mutant mice appear hyperactive.  Therefore, 
the Arx-/Y Emx1Cre mice have an abnormal EEG background consistent with particular 
ARX mutations in humans and ADHD patients. 
This increase of slower frequencies and a decrease of faster frequencies seen in 
the Arx-/Y Emx1Cre mice is the opposite of the Arx-/Y Dlx5/6Cre mice, which have a 
decrease of slower frequencies and an increase of faster frequencies.  In the Arx-/Y 
Dlx5/6Cre mice, Arx is lost only in the ganglionic eminence and its derivatives, the 
cortical interneurons, which generally have inhibitory roles in cortical circuits.  The result 
is fewer interneurons in the cortex, which presumably results in the observed decreased 
inhibition relative to excitation in the cortex.  This imbalance of inhibition relative to 
excitation is thought to be the cause of seizures in these mice and in ARX patients.  In the 
Arx-/Y Emx1Cre mice the opposite is true, loss of Arx causes a loss of layer 2/3 pyramidal 
cells which are excitatory and the interneurons are spared so presumably there would be 
an increase in the inhibition in these cortices relative to the excitation.  These intriguing 
results provide the first data that the removal of particular cell types from the cortex can 
cause specific changes in murine cortical EEG patterns.  This represents, to the best of 
my knowledge, the first example where the relative loss of inhibition in the cortex 
decreases slow EEG frequencies and increases fast frequencies while a relative loss of 
excitation only in the cortex induces an EEG shift to slower frequencies and a decrease of 
fast frequencies.   
 Described above is one possible theory to explain our observations regarding the 
disparate EEGs of these two Arx conditional knockout mice.  To further validate this 
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theory we would have to first show that there actually is a relative loss of inhibition or 
excitation in the cortices of these two conditional knockout mice.  This could be done by 
recording field potentials in cortical slices of each of these mice.  If these EEGs did 
correlate with relative inhibition of excitation in the cortex then the next step would be to 
find or generate additional mutant mice which are missing either particular excitatory or 
inhibitory cells, preferably distinct from those lost in the mice we generated and from 
other genetic mutations and examine the EEG recordings and field potentials of these 
mutant mice as well.  If particular EEG changes could be found to correlate with loss of 
particular cell types in the cortex then EEGs in people could be used to diagnose more 
diseases and hopefully lead to more specific treatments. 
Behavioral Phenotype of Arx-/Y Emx1Cre mice  
 Patients with ARX mutations exhibit a spectrum of phenotypes with some 
mutations having major structural brain malformations and others having normal 
appearing brains.  However, all ARX patients have some type of seizure disorder and 
some level of intellectual disability (Marsh ED and JA Golden 2012).  The Arx-/Y Emx1Cre 
mice do not have seizures and have a normal lifespan, unlike most other Arx mutant 
mice, but they do have morphological changes of their brains (Chapter 2: Fig. 1; Chapter 
3: Fig. 1).  Their cortex is smaller and thinner with a specific loss of superficial excitatory 
neurons and their amygdala is smaller with fewer neurons in the basolateral amygdala.  
They also have defects of white matter tracts in the brain including the corpus callosum 
and the anterior commissure.  Given these various anomalies we next sought to determine 
if these morphological changes correlated with possible behavior anomalies.  Since most 
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mutations of ARX in people result in some form of intellectual disability we first tested 
the learning and memory of the Arx-/Y Emx1Cre mice.  To our surprise, the mice had 
normal learning in all modalities tested.  Spatial learning and memory, fear based 
learning, and reversal learning were all normal (Chapter 3: Fig. 4).  This is most 
consistent with the fact that these mice do not have hippocampal defects.  In rodents the 
hippocampus drives much of the learning phenotype and it is normal in these animals.   
 The Arx-/Y Emx1Cre mice were also put through several anxiety tests and they were 
found to be less anxious, more exploratory, and more active than their wild type 
littermates (Chapter 3: Fig. 6).  This anxiolytic and hyperactive phenotype could be the 
result of the loss of neurons in the cortex or the amygdala or the loss of connections 
within the limbic system.  These mice also have a social deficit, an autistic feature, which 
could also be related to this loss of neurons in the cortex and amygdala or a loss of 
cortical connections (Chapter 3: Fig. 8).  
Three other Arx mutant mice (Arx(GCG)7/Y, ArxPL/Y, Arx(GCG)10+7) have been 
behaviorally phenotyped by two other labs and they have some similarities and 
differences to the Arx-/Y Emx1Cre mice.  The other three Arx mutant mice all have 
impaired spatial learning and fear-based learning (Kitamura K et al. 2009; Price MG et al. 
2009).  The Arx(GCG)7/Y and ArxPL/Y mice are more anxious than their wild type littermates, 
while the Arx(GCG)10+7 mice are less anxious, more active, and have social deficits similar 
to the Arx-/Y;Emx1Cre mice (Kitamura K et al. 2009; Price MG et al. 2009).  The 
Arx(GCG)7/Y mice and the Arx(GCG)10+7 mice have severe seizures and die at a young age 
(Kitamura K et al. 2009; Price MG et al. 2009).  Only a few ArxPL/Y mice have seizures, 
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which are much less severe than the Arx(GCG)7/Y and Arx(GCG)10+7 mice and they have a 
normal lifespan (Kitamura K et al. 2009).  None of these Arx mutants have exactly the 
same behavioral phenotype as the Arx-/Y Emx1Cre mice, but this is to be expected since the 
Arx-/Y Emx1Cre mouse is a conditional knockout that only affects part of the brain.  While 
the other mutations may only affect part of the function of Arx, but are present in the 
whole brain.   
The morphological phenotype of these mutant mice also differs. The Arx(GCG)7/Y, 
ArxPL/Y, and Arx(GCG)10+7 mice do not have the thinner cortex with an abnormal layer 
structure and agenesis of the corpus callosum that is seen in the Arx knockout mouse and 
the Arx-/Y Emx1Cre mouse, which could indicate that cortical progenitor cell proliferation 
is not affected by these particular mutations to Arx (Kitamura K et al. 2009; Price MG et 
al. 2009).  However, the Arx(GCG)7/Y, ArxPL/Y, and Arx(GCG)10+7 mice have a loss of 
interneurons in the cortex, hippocampus, and striatum while the Arx-/Y Emx1Cre mice have 
normal numbers of interneurons. Interestingly, Arx-/Y Dlx5/6Cre mice, where Arx is only 
removed from the GE derived cortical interneurons, also do not have a thinner cortex 
with abnormal layering and agenesis of the corpus callosum.  This also shows that this 
morphological phenotype is caused by changes to the cortical progenitor cells and not the 
interneurons (Marsh E et al. 2009).  
The Arx(GCG)7/Y, ArxPL/Y, and Arx(GCG)10+7 mice all have some degree of epilepsy, 
learning deficits, and a loss of interneurons although given their seizure frequency this 
can be difficult to assess, whereas the Arx-/Y Emx1Cre mice have none of these 
characteristics (Kitamura K et al. 2009; Price MG et al. 2009).  Therefore, we can 
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hypothesize that loss of interneurons is necessary for the development of epilepsy and 
learning deficits both in these mice and presumably in human ARX patients.  The Arx-/Y 
Emx1Cre mice provide negative evidence that the epilepsy in ARX patients is caused by 
problems with interneuron development and not the brain malformations seen in these 
patients.  These mice also provide evidence that the behavioral and cognitive deficits seen 
in ARX patients might not be caused by the epilepsy.  If this is true then the current 
clinical dogma that controlling the epilepsy of these patients early on will improve their 
cognitive and behavioral outcomes is incorrect and these patients may have the same 
behavioral and cognitive deficits regardless of how well their epilepsy is controlled.  
The morphological and behavioral phenotype of the Arx-/Y Emx1Cre mice makes 
them a reasonable model to investigate the pathobiology underlying patients with mild 
ARX mutations such as those with nonsyndromic X-linked intellectual disability, Proud 
syndrome, Partington syndrome, and females with ARX mutations (Suri M 2005; 
Shoubridge C et al. 2010).  These mice could be used in future studies to understand how 
the brains of these patients are altered and how these changes led to their particular 
behavioral phenotypes.  Once their phenotype is better understood they could also be 
used to evaluate treatment options for these patients.  
Connecting anxiety and autistic behaviors to changes in development 
The other behaviors (low anxiety, hyperactivity, and social deficits) seen in 
various Arx mutant mice (Arx-/Y Emx1Cre, Arx(GCG)7/Y, ArxPL/Y, and Arx(GCG)10+7 ) are more 
difficult to attribute to a particular function of Arx or to particular groups of neurons in 
the cortex.  One reason for this is that these behaviors are controlled by the limbic 
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system, which involves the entorhinal and pyriform cortex, amygdala, hippocampus, and 
the connections between them.  It has been reported that Arx is expressed in cells in the 
adult amygdala, but its function in the amygdala has not been investigated (Poirier K et 
al. 2004).  We have shown that in the Arx-/Y Emx1Cre mice there are fewer neurons in the 
basolateral amygdala.  It would be interesting to look at whether other Arx mutant mice 
also have a loss of neurons in the basolateral amygdala or perhaps to examine other 
amygdala nuclei.  If there is found to be consistent loss of neurons in the basolateral 
amygdala of the Arx mutant mice then this could be a potential explanation for the 
changes in anxiety and social behaviors in these mice.   
A possible future direction of this work would be to examine which particular 
neurons are lost from the basolateral amygdala of the Arx-/Y Emx1Cre mice or from other 
Arx mutant mice.  I would hypothesize that excitatory neurons are lost in the Arx-/Y 
Emx1Cre mice because interneurons are born in the ventral areas of the brain that do not 
express Emx1 and these mice have normal numbers of interneurons in the cortex.  To test 
this we could stain amygdala sections from the Arx-/Y Emx1Cre mice for Tbr1 or Mef2c or 
do in situ hybridizations for Foxp2 or Meis2, which should all mark excitatory neurons in 
the amygdala and compare the numbers of those cells in the mutant mice to their wild 
type littermates (Remedios R et al. 2007; Waclaw RR et al. 2010; Cocas LA et al. 2011).  
We could also label GAD67, Parv, or SST as we did with the cortex to confirm that there 
is no loss of GABAergic neurons subtypes in the amygdala of these mice.  Performing 
similar studies on the other Arx mutant mice to determine which, if any, of the neuronal 
subtypes are lost could also be informative in understanding both the role of Arx in 
development and the consequences of specific neuronal loss to behavior.  If these 
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experiments were done, I would hypothesize that the Arx(GCG)7/Y and ArxPL/Y mutant mice 
would have a loss of interneurons and/or GABAergic projections neurons in the 
amygdala and no loss of excitatory cells similar to what has been demonstrated in the 
cortex.  Perhaps the loss of different subtypes of neurons in the amygdala could explain 
the differences in anxiety behaviors seen in the different Arx mutant mice.  
Another future direction of this work could be to examine whether connections 
between the cortex and amygdala are lost in the Arx-/Y Emx1Cre mice either because of a 
loss of neurons in the cortex or a loss of neurons in the amygdala.  As with the white 
matter tract studies, a labeling study using DiI or Neurobiotin in the dorsolateral 
prefrontal cortex or anterior cingulate cortex could determine if there are fewer 
projections to or from the amygdala in the Arx-/Y Emx1Cre mice.  Conversely injections 
into the basolateral and lateral amygdala could be performed to trace the cortical-
amygdala projections.  If the Arx-/Y Emx1Cre mice are missing connections between the 
cortex and the amygdala then the other Arx mutant mice should also be examined to 
determine if they are missing the same connections and if they are missing connections 
between the cortex and the amygdala that could be another explanation for the anxiety, 
hyperactivity, and social deficits and could bring us closer to understanding the human 
behavioral phenotype.  
Ideally, to learn if any behavioral deficit could be correlated with specific cellular 
or regional dysfunction related to Arx loss, one could use a more specific Cre line to 
remove Arx either from the cortex, cortical subregions, such as prefrontal or 
somatosensory, the amygdala or particular subnuclei.  If such specific Cre lines could be 
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developed the anxiety, hyperactivity, and social deficit behaviors of the resulting mice 
could be examined and correlated with the underlying structural changes in the cortex, 
amygdala or connections between the two.   
Arx has different functions in different parts of the brain  
Previous research on Arx has focused on where and when it is expressed during 
development and what happens to the brain when it is absent or mutated (Kitamura K et 
al. 2002; Kitamura K et al. 2009; Price MG et al. 2009).  There has also been research 
into what genes Arx regulates and how different mutations change its DNA binding and 
repressive activities (McKenzie O et al. 2007; Colasante G et al. 2009; Quille ML et al. 
2011; Cho G et al. 2012; Nasrallah MP et al. 2012; Shoubridge C et al. 2012).  These 
studies provide one explanation for the spectrum of phenotypes seen in human patients, a 
close though not perfect genotype-phenotype correlation.  For example an Arx protein 
with a polyalanine expansion can bind to three of its known target genes (Lmo1, Shox2, 
and Ebf3) but it can only repress Shox2 and Lmo1 (McKenzie O et al. 2007; Nasrallah 
MP et al. 2012).  While an Arx protein with a mutation in its homeodomain cannot bind 
to or repress any of these three target genes (Cho G et al. 2012; Shoubridge C et al. 
2012).  Therefore, the phenotype of the homeodomain mutations is worse because the 
protein is completely non-functional whereas the polyalanine expansion Arx mutation is 
partially functional. 
However, another explanation for the spectrum of phenotypes could be that Arx 
has different functions in different cell types and some of the functions can be 
accomplished by some mutations of Arx, but not by others.  This would occur if different 
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cell types have different cofactors that Arx interacts with to regulate different groups of 
genes and some mutations may abolish binding to some cofactors but not others.  Our lab 
recently found that Arx with a polyalanine expansion has reduced binding to its known 
cofactor Tle1, which could explain why it can no longer bind to the promoter regions of 
Shox2 and Ebf3 (Nasrallah MP et al. 2012).  Therefore, a future direction for the field 
would be to look for cofactors of Arx and try to determine if different cell types at 
different points in development express particular cofactors and this correlates with the 
expression of particular groups of genes associated with particular cellular functions.  
Our data has already provided some evidence for this alternative explanation for 
the spectrum of ARX phenotypes.  We have shown that Arx functions to regulate cell 
cycle exit of progenitor cells in the cortex by regulating a distinct cohort of genes, 
particularly Cdkn1c, from those already shown to be regulated in interneurons.  
Therefore, loss of Arx in the cortical progenitor cells results in changes in the structure 
and function of the cortex that are different from the changes in function that result from 
the loss of Arx in interneurons.  When Arx is lost in the cortical progenitor cells the adult 
animal has a thinner cortex and agenesis of the corpus callosum, but does not have 
seizures.  Whereas the removal of Arx from interneurons results in an animal with a 
normal appearing cortex that has fewer interneurons and does have seizures, which it 
often succumbs to before adulthood (Marsh E et al. 2009).  
Prior to the results presented here, Arx was known to function in cortical 
proliferation and differentiation, but the exact mechanism was not known.  We have now 
revealed that Arx is regulating the cell cycle exit of cortical progenitor cells in the cortex 
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by repressing the cyclin dependent kinase inhibitor Cdkn1c.  This results in premature 
exit of progenitor cells from the cell cycle, which ultimately results in a thinner cortex 
due to loss of neurons from the superficial layers.  We have correlated this finding in 
adult mutant mice with lower anxiety, hyperactivity, and social deficits, providing 
evidence for the cell types and circuits that are involved in these behaviors in mice and 
presumably in humans.  Hence, these mice can serve as a model of mild human ARX 
patients and could aid in the understanding of both the physiology of the disease and be 
used to test possible treatments for these behavioral symptoms. 
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